NO138695B - ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TRICYCLIC COMPOUNDS - Google Patents
ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TRICYCLIC COMPOUNDS Download PDFInfo
- Publication number
- NO138695B NO138695B NO296373A NO296373A NO138695B NO 138695 B NO138695 B NO 138695B NO 296373 A NO296373 A NO 296373A NO 296373 A NO296373 A NO 296373A NO 138695 B NO138695 B NO 138695B
- Authority
- NO
- Norway
- Prior art keywords
- water
- dihydro
- dibenzo
- acid
- solution
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims description 31
- 238000000034 method Methods 0.000 title claims description 5
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims description 15
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical group 0.000 claims description 7
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 claims description 3
- 125000005277 alkyl imino group Chemical group 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 229910052760 oxygen Inorganic materials 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 150
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 132
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 88
- 239000000243 solution Substances 0.000 description 79
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 72
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 70
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 68
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 52
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 49
- 239000012074 organic phase Substances 0.000 description 49
- 238000010992 reflux Methods 0.000 description 49
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 45
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 45
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 30
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 30
- 239000003921 oil Substances 0.000 description 30
- 235000019198 oils Nutrition 0.000 description 30
- -1 sulfonyloxy Chemical class 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 29
- 239000011541 reaction mixture Substances 0.000 description 29
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 28
- 229910052938 sodium sulfate Inorganic materials 0.000 description 27
- 235000011152 sodium sulphate Nutrition 0.000 description 27
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 26
- 235000019341 magnesium sulphate Nutrition 0.000 description 26
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 25
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 25
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 24
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- 239000000155 melt Substances 0.000 description 21
- 239000002253 acid Substances 0.000 description 20
- 239000007858 starting material Substances 0.000 description 20
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 18
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 18
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 16
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 15
- 235000011121 sodium hydroxide Nutrition 0.000 description 15
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 13
- 238000003756 stirring Methods 0.000 description 13
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 12
- 239000012299 nitrogen atmosphere Substances 0.000 description 12
- 235000017557 sodium bicarbonate Nutrition 0.000 description 12
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 12
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
- 239000011976 maleic acid Substances 0.000 description 11
- 229940098895 maleic acid Drugs 0.000 description 11
- 229910000033 sodium borohydride Inorganic materials 0.000 description 11
- 239000012279 sodium borohydride Substances 0.000 description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 10
- 239000005457 ice water Substances 0.000 description 10
- 230000007935 neutral effect Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Substances OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- 229910000027 potassium carbonate Inorganic materials 0.000 description 9
- 229920006395 saturated elastomer Polymers 0.000 description 9
- 239000000725 suspension Substances 0.000 description 9
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 229960000583 acetic acid Drugs 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 239000001110 calcium chloride Substances 0.000 description 8
- 229910001628 calcium chloride Inorganic materials 0.000 description 8
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 7
- 229960001076 chlorpromazine Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 230000000701 neuroleptic effect Effects 0.000 description 7
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 229910052783 alkali metal Inorganic materials 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 6
- 239000003208 petroleum Substances 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 230000002903 catalepsic effect Effects 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 229920000137 polyphosphoric acid Polymers 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000017550 sodium carbonate Nutrition 0.000 description 5
- XMSIKZYHNRPQEG-UHFFFAOYSA-N 3-(2-piperazin-1-ylethyl)-1,3-oxazolidin-2-one Chemical compound O=C1OCCN1CCN1CCNCC1 XMSIKZYHNRPQEG-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 230000001143 conditioned effect Effects 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 239000003480 eluent Substances 0.000 description 4
- 238000011067 equilibration Methods 0.000 description 4
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 4
- LNOQURRKNJKKBU-UHFFFAOYSA-N ethyl piperazine-1-carboxylate Chemical compound CCOC(=O)N1CCNCC1 LNOQURRKNJKKBU-UHFFFAOYSA-N 0.000 description 4
- KDCIHNCMPUBDKT-UHFFFAOYSA-N hexane;propan-2-one Chemical compound CC(C)=O.CCCCCC KDCIHNCMPUBDKT-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 4
- 235000019345 sodium thiosulphate Nutrition 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- WEKDWCDZPOVNCP-UHFFFAOYSA-N 2-(5-nitro-2-phenylsulfanylphenyl)acetic acid Chemical compound OC(=O)CC1=CC([N+]([O-])=O)=CC=C1SC1=CC=CC=C1 WEKDWCDZPOVNCP-UHFFFAOYSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CDYDZTYVCIPLHY-UHFFFAOYSA-N 3-(2-chloroethyl)-1,3-oxazolidin-2-one Chemical compound ClCCN1CCOC1=O CDYDZTYVCIPLHY-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 239000005909 Kieselgur Substances 0.000 description 3
- 239000012448 Lithium borohydride Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 239000004133 Sodium thiosulphate Substances 0.000 description 3
- 150000001340 alkali metals Chemical class 0.000 description 3
- 239000012300 argon atmosphere Substances 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 239000003874 central nervous system depressant Substances 0.000 description 3
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 150000002081 enamines Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000012362 glacial acetic acid Substances 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 239000003176 neuroleptic agent Substances 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000004540 pour-on Substances 0.000 description 3
- 125000006239 protecting group Chemical group 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 235000010288 sodium nitrite Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- ZYUDAIAKGACNCP-UHFFFAOYSA-N 1-(3-chloro-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)piperazine Chemical compound C1C2=CC(Cl)=CC=C2SC2=CC=CC=C2C1N1CCNCC1 ZYUDAIAKGACNCP-UHFFFAOYSA-N 0.000 description 2
- KBVYFYMKGQPPCT-UHFFFAOYSA-N 1-(3-methyl-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)piperazine Chemical compound C1C2=CC(C)=CC=C2SC2=CC=CC=C2C1N1CCNCC1 KBVYFYMKGQPPCT-UHFFFAOYSA-N 0.000 description 2
- HACPYCSCTDPVMX-UHFFFAOYSA-N 2-(5-bromo-2-phenylsulfanylphenyl)acetic acid Chemical compound OC(=O)CC1=CC(Br)=CC=C1SC1=CC=CC=C1 HACPYCSCTDPVMX-UHFFFAOYSA-N 0.000 description 2
- WWWSAAZMUFZPIO-UHFFFAOYSA-N 2-(5-bromo-2-phenylsulfanylphenyl)acetonitrile Chemical compound N#CCC1=CC(Br)=CC=C1SC1=CC=CC=C1 WWWSAAZMUFZPIO-UHFFFAOYSA-N 0.000 description 2
- UTUVZBGLCMDOHJ-UHFFFAOYSA-N 2-(5-fluoro-2-phenylsulfanylphenyl)acetonitrile Chemical compound N#CCC1=CC(F)=CC=C1SC1=CC=CC=C1 UTUVZBGLCMDOHJ-UHFFFAOYSA-N 0.000 description 2
- HNNGXGIBBSRCIO-UHFFFAOYSA-N 2-(5-methyl-2-phenylsulfanylphenyl)acetic acid Chemical compound OC(=O)CC1=CC(C)=CC=C1SC1=CC=CC=C1 HNNGXGIBBSRCIO-UHFFFAOYSA-N 0.000 description 2
- YOJOZSZPUGBSGO-UHFFFAOYSA-N 2-(5-methyl-2-phenylsulfanylphenyl)acetonitrile Chemical compound N#CCC1=CC(C)=CC=C1SC1=CC=CC=C1 YOJOZSZPUGBSGO-UHFFFAOYSA-N 0.000 description 2
- DVFPKSJISWQIGL-UHFFFAOYSA-N 2-(5-nitro-2-phenylsulfanylphenyl)acetonitrile Chemical compound N#CCC1=CC([N+](=O)[O-])=CC=C1SC1=CC=CC=C1 DVFPKSJISWQIGL-UHFFFAOYSA-N 0.000 description 2
- XMBXKRJDTXULSA-UHFFFAOYSA-N 2-(chloromethyl)-4-fluoro-1-phenylsulfanylbenzene Chemical compound ClCC1=CC(F)=CC=C1SC1=CC=CC=C1 XMBXKRJDTXULSA-UHFFFAOYSA-N 0.000 description 2
- OXKHZQUQICOEOY-UHFFFAOYSA-N 2-(chloromethyl)-4-nitro-1-phenylsulfanylbenzene Chemical compound ClCC1=CC([N+](=O)[O-])=CC=C1SC1=CC=CC=C1 OXKHZQUQICOEOY-UHFFFAOYSA-N 0.000 description 2
- YSDLQQBEOZRPMP-UHFFFAOYSA-N 2-[2-phenylsulfanyl-5-(trifluoromethyl)phenyl]acetic acid Chemical compound OC(=O)CC1=CC(C(F)(F)F)=CC=C1SC1=CC=CC=C1 YSDLQQBEOZRPMP-UHFFFAOYSA-N 0.000 description 2
- HNWKCLDASLNCDM-UHFFFAOYSA-N 2-[2-phenylsulfanyl-5-(trifluoromethyl)phenyl]acetonitrile Chemical compound N#CCC1=CC(C(F)(F)F)=CC=C1SC1=CC=CC=C1 HNWKCLDASLNCDM-UHFFFAOYSA-N 0.000 description 2
- INGWGCDYAJKXKP-UHFFFAOYSA-N 2-iodo-5-methylbenzoic acid Chemical compound CC1=CC=C(I)C(C(O)=O)=C1 INGWGCDYAJKXKP-UHFFFAOYSA-N 0.000 description 2
- UBCNQWMQLBEUOC-UHFFFAOYSA-N 2-nitro-1-phenylsulfanyl-4-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1SC1=CC=CC=C1 UBCNQWMQLBEUOC-UHFFFAOYSA-N 0.000 description 2
- ZCXKHYUBKCKFQD-UHFFFAOYSA-N 2-phenylsulfanyl-5-(trifluoromethyl)aniline Chemical compound NC1=CC(C(F)(F)F)=CC=C1SC1=CC=CC=C1 ZCXKHYUBKCKFQD-UHFFFAOYSA-N 0.000 description 2
- QTOLCTUWRPDFOF-UHFFFAOYSA-N 2-phenylsulfanyl-5-(trifluoromethyl)benzoic acid Chemical compound OC(=O)C1=CC(C(F)(F)F)=CC=C1SC1=CC=CC=C1 QTOLCTUWRPDFOF-UHFFFAOYSA-N 0.000 description 2
- GLHKBIKSXBHAAO-UHFFFAOYSA-N 2-phenylsulfanyl-5-(trifluoromethyl)benzonitrile Chemical compound N#CC1=CC(C(F)(F)F)=CC=C1SC1=CC=CC=C1 GLHKBIKSXBHAAO-UHFFFAOYSA-N 0.000 description 2
- CFKDHZJAQJDDJW-UHFFFAOYSA-N 3-(3-chloropropyl)-1,3-oxazolidin-2-one Chemical compound ClCCCN1CCOC1=O CFKDHZJAQJDDJW-UHFFFAOYSA-N 0.000 description 2
- GHSDWRIJPALILV-UHFFFAOYSA-N 3-fluoro-5,6-dihydrobenzo[b][1]benzothiepin-6-ol Chemical compound OC1CC2=CC(F)=CC=C2SC2=CC=CC=C12 GHSDWRIJPALILV-UHFFFAOYSA-N 0.000 description 2
- HGMFVSUJWOQJJF-UHFFFAOYSA-N 3-methyl-5,6-dihydrobenzo[b][1]benzothiepin-6-ol Chemical compound OC1CC2=CC(C)=CC=C2SC2=CC=CC=C21 HGMFVSUJWOQJJF-UHFFFAOYSA-N 0.000 description 2
- LUPGRNZLGSKDLJ-UHFFFAOYSA-N 3-methyl-5h-benzo[b][1]benzothiepin-6-one Chemical compound O=C1CC2=CC(C)=CC=C2SC2=CC=CC=C21 LUPGRNZLGSKDLJ-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- RREQLBSQVMLXRJ-UHFFFAOYSA-N 4-bromo-2-(chloromethyl)-1-phenylsulfanylbenzene Chemical compound ClCC1=CC(Br)=CC=C1SC1=CC=CC=C1 RREQLBSQVMLXRJ-UHFFFAOYSA-N 0.000 description 2
- CDRVTBTWSLURRN-UHFFFAOYSA-N 5-bromo-2-phenylsulfanylbenzoic acid Chemical compound OC(=O)C1=CC(Br)=CC=C1SC1=CC=CC=C1 CDRVTBTWSLURRN-UHFFFAOYSA-N 0.000 description 2
- XPFMQYOPTHMSJJ-UHFFFAOYSA-N 5-fluoro-2-iodobenzoic acid Chemical compound OC(=O)C1=CC(F)=CC=C1I XPFMQYOPTHMSJJ-UHFFFAOYSA-N 0.000 description 2
- RWIODUJYRUEMRB-UHFFFAOYSA-N 5-fluoro-2-phenylsulfanylbenzoic acid Chemical compound OC(=O)C1=CC(F)=CC=C1SC1=CC=CC=C1 RWIODUJYRUEMRB-UHFFFAOYSA-N 0.000 description 2
- XWIWOASJHKVEKI-UHFFFAOYSA-N 5-nitro-2-phenylsulfanylbenzaldehyde Chemical compound O=CC1=CC([N+](=O)[O-])=CC=C1SC1=CC=CC=C1 XWIWOASJHKVEKI-UHFFFAOYSA-N 0.000 description 2
- ZJDJJUATDQXJQZ-UHFFFAOYSA-N 6-chloro-3-(trifluoromethyl)-5,6-dihydrobenzo[b][1]benzothiepine Chemical compound ClC1CC2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 ZJDJJUATDQXJQZ-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 2
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 2
- 239000007859 condensation product Substances 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 239000012954 diazonium Substances 0.000 description 2
- 150000001989 diazonium salts Chemical class 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 150000003951 lactams Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- HYOIQESAENEELY-UHFFFAOYSA-N methyl 2-phenylsulfanyl-5-(trifluoromethyl)benzoate Chemical compound COC(=O)C1=CC(C(F)(F)F)=CC=C1SC1=CC=CC=C1 HYOIQESAENEELY-UHFFFAOYSA-N 0.000 description 2
- OCFQMDQJVZSZCV-UHFFFAOYSA-N methyl 5-bromo-2-phenylsulfanylbenzoate Chemical compound COC(=O)C1=CC(Br)=CC=C1SC1=CC=CC=C1 OCFQMDQJVZSZCV-UHFFFAOYSA-N 0.000 description 2
- DEBKKJLVTOPRNQ-UHFFFAOYSA-N methyl 5-methyl-2-phenylsulfanylbenzoate Chemical compound COC(=O)C1=CC(C)=CC=C1SC1=CC=CC=C1 DEBKKJLVTOPRNQ-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000006408 oxalic acid Nutrition 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 201000000980 schizophrenia Diseases 0.000 description 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- GOQGGGANVKPMNH-UHFFFAOYSA-N (4-hydroxy-3-methoxyphenyl)acetaldehyde Chemical compound COC1=CC(CC=O)=CC=C1O GOQGGGANVKPMNH-UHFFFAOYSA-N 0.000 description 1
- UUIRYUCYUDCIKX-UHFFFAOYSA-N (5-nitro-2-phenylsulfanylphenyl)methanol Chemical compound OCC1=CC([N+]([O-])=O)=CC=C1SC1=CC=CC=C1 UUIRYUCYUDCIKX-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- QPKIGUBDVDOQEX-BTJKTKAUSA-N (z)-but-2-enedioic acid;3-[2-[4-(3-chloro-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)piperazin-1-yl]ethyl]-1,3-oxazolidin-2-one Chemical compound OC(=O)\C=C/C(O)=O.C1C2=CC(Cl)=CC=C2SC2=CC=CC=C2C1N(CC1)CCN1CCN1CCOC1=O QPKIGUBDVDOQEX-BTJKTKAUSA-N 0.000 description 1
- ODVVKGPPFPLMAI-UHFFFAOYSA-N 1-(2-chloroethyl)piperidin-2-one Chemical compound ClCCN1CCCCC1=O ODVVKGPPFPLMAI-UHFFFAOYSA-N 0.000 description 1
- CWLYHDWHNFLUEI-UHFFFAOYSA-N 1-(2-chloroethyl)pyrrolidin-2-one Chemical compound ClCCN1CCCC1=O CWLYHDWHNFLUEI-UHFFFAOYSA-N 0.000 description 1
- IQXXEPZFOOTTBA-UHFFFAOYSA-N 1-benzylpiperazine Chemical compound C=1C=CC=CC=1CN1CCNCC1 IQXXEPZFOOTTBA-UHFFFAOYSA-N 0.000 description 1
- TZGFQIXRVUHDLE-UHFFFAOYSA-N 1-chloro-2-nitro-4-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(C(F)(F)F)=CC=C1Cl TZGFQIXRVUHDLE-UHFFFAOYSA-N 0.000 description 1
- CJQPTERCDVUXQY-UHFFFAOYSA-N 2-(5-fluoro-2-phenylsulfanylphenyl)acetic acid Chemical compound OC(=O)CC1=CC(F)=CC=C1SC1=CC=CC=C1 CJQPTERCDVUXQY-UHFFFAOYSA-N 0.000 description 1
- QFURCCWNTXDDSZ-UHFFFAOYSA-N 2-(chloromethyl)-1-phenylsulfanyl-4-(trifluoromethyl)benzene Chemical compound ClCC1=CC(C(F)(F)F)=CC=C1SC1=CC=CC=C1 QFURCCWNTXDDSZ-UHFFFAOYSA-N 0.000 description 1
- VMIHMHPIYVGHSV-UHFFFAOYSA-N 2-(chloromethyl)-4-methyl-1-phenylsulfanylbenzene Chemical compound ClCC1=CC(C)=CC=C1SC1=CC=CC=C1 VMIHMHPIYVGHSV-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- NFSGHDXTKLVKSD-UHFFFAOYSA-N 2-amino-5-fluorobenzoic acid;hydrochloride Chemical compound Cl.NC1=CC=C(F)C=C1C(O)=O NFSGHDXTKLVKSD-UHFFFAOYSA-N 0.000 description 1
- NBUUUJWWOARGNW-UHFFFAOYSA-N 2-amino-5-methylbenzoic acid Chemical compound CC1=CC=C(N)C(C(O)=O)=C1 NBUUUJWWOARGNW-UHFFFAOYSA-N 0.000 description 1
- VFVHWCKUHAEDMY-UHFFFAOYSA-N 2-chloro-5-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(Cl)C(C=O)=C1 VFVHWCKUHAEDMY-UHFFFAOYSA-N 0.000 description 1
- SFTJKCPNRHYWEO-UHFFFAOYSA-N 3-(2-chloroethyl)-1h-benzimidazol-2-one Chemical compound C1=CC=C2NC(=O)N(CCCl)C2=C1 SFTJKCPNRHYWEO-UHFFFAOYSA-N 0.000 description 1
- POXHVHJFMRAXIC-UHFFFAOYSA-N 3-(trifluoromethyl)-5h-benzo[b][1]benzothiepin-6-one Chemical compound O=C1CC2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C21 POXHVHJFMRAXIC-UHFFFAOYSA-N 0.000 description 1
- NEWDJEUFDGKJCY-UHFFFAOYSA-N 3-[2-(4-benzylpiperazin-1-yl)ethyl]-1,3-oxazolidin-2-one;dihydrochloride Chemical compound Cl.Cl.O=C1OCCN1CCN1CCN(CC=2C=CC=CC=2)CC1 NEWDJEUFDGKJCY-UHFFFAOYSA-N 0.000 description 1
- JPLXOENIKHJZFL-UHFFFAOYSA-N 3-[2-[4-(3-chloro-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)piperazin-1-yl]ethyl]-1,3-oxazolidin-2-one Chemical compound C1C2=CC(Cl)=CC=C2SC2=CC=CC=C2C1N(CC1)CCN1CCN1CCOC1=O JPLXOENIKHJZFL-UHFFFAOYSA-N 0.000 description 1
- LXHYJMFNHOSMSW-UHFFFAOYSA-N 3-[2-[4-[3-(trifluoromethyl)-5,6-dihydrobenzo[b][1]benzothiepin-6-yl]piperazin-1-yl]ethyl]-1,3-oxazolidin-2-one Chemical compound C1C2=CC(C(F)(F)F)=CC=C2SC2=CC=CC=C2C1N(CC1)CCN1CCN1CCOC1=O LXHYJMFNHOSMSW-UHFFFAOYSA-N 0.000 description 1
- UVLBTHWVIHJSFE-UHFFFAOYSA-N 3-[3-[4-(3-methyl-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)piperazin-1-yl]propyl]-1,3-oxazolidin-2-one Chemical compound C1C2=CC(C)=CC=C2SC2=CC=CC=C2C1N(CC1)CCN1CCCN1CCOC1=O UVLBTHWVIHJSFE-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- COPGPVWJZSIOLC-UHFFFAOYSA-N 3-bromo-5,6-dihydrobenzo[b][1]benzothiepin-6-ol Chemical compound OC1CC2=CC(Br)=CC=C2SC2=CC=CC=C12 COPGPVWJZSIOLC-UHFFFAOYSA-N 0.000 description 1
- VKDLTOVJSBQLAL-UHFFFAOYSA-N 3-chloro-5h-benzo[b][1]benzothiepin-6-one Chemical compound O=C1CC2=CC(Cl)=CC=C2SC2=CC=CC=C21 VKDLTOVJSBQLAL-UHFFFAOYSA-N 0.000 description 1
- KQUFHMMWHDEJSL-UHFFFAOYSA-N 3-fluoro-5h-benzo[b][1]benzothiepin-6-one Chemical compound O=C1CC2=CC(F)=CC=C2SC2=CC=CC=C21 KQUFHMMWHDEJSL-UHFFFAOYSA-N 0.000 description 1
- ZEUHGWGJFWIXHE-UHFFFAOYSA-N 3-iodo-5,6-dihydrobenzo[b][1]benzothiepin-6-ol Chemical compound OC1CC2=CC(I)=CC=C2SC2=CC=CC=C12 ZEUHGWGJFWIXHE-UHFFFAOYSA-N 0.000 description 1
- QTZKTTPFMVPDKN-UHFFFAOYSA-N 3-nitro-5h-benzo[b][1]benzothiepin-6-one Chemical compound O=C1CC2=CC([N+](=O)[O-])=CC=C2SC2=CC=CC=C21 QTZKTTPFMVPDKN-UHFFFAOYSA-N 0.000 description 1
- IGBNDUKRHPTOBP-UHFFFAOYSA-N 5-bromo-2-iodobenzoic acid Chemical compound OC(=O)C1=CC(Br)=CC=C1I IGBNDUKRHPTOBP-UHFFFAOYSA-N 0.000 description 1
- RVRNJDIRDPQVLJ-UHFFFAOYSA-N 5-methyl-2-phenylsulfanylbenzoic acid Chemical compound OC(=O)C1=CC(C)=CC=C1SC1=CC=CC=C1 RVRNJDIRDPQVLJ-UHFFFAOYSA-N 0.000 description 1
- CGHAAXYJLWOSFS-UHFFFAOYSA-N 6-chloro-3-fluoro-5,6-dihydrobenzo[b][1]benzothiepine Chemical compound ClC1CC2=CC(F)=CC=C2SC2=CC=CC=C21 CGHAAXYJLWOSFS-UHFFFAOYSA-N 0.000 description 1
- DORPTMGRVDEQKW-UHFFFAOYSA-N 6-chloro-3-methyl-5,6-dihydrobenzo[b][1]benzothiepine Chemical compound ClC1CC2=CC(C)=CC=C2SC2=CC=CC=C21 DORPTMGRVDEQKW-UHFFFAOYSA-N 0.000 description 1
- FQQKBXBQGGRURX-UHFFFAOYSA-N 6-chloro-3-nitro-5,6-dihydrobenzo[b][1]benzothiepine Chemical compound ClC1CC2=CC([N+](=O)[O-])=CC=C2SC2=CC=CC=C21 FQQKBXBQGGRURX-UHFFFAOYSA-N 0.000 description 1
- TYPOAKWKONCBGF-UHFFFAOYSA-N 6-chloro-n,n-dimethyl-5,6-dihydrobenzo[b][1]benzothiepine-3-sulfonamide Chemical compound ClC1CC2=CC(S(=O)(=O)N(C)C)=CC=C2SC2=CC=CC=C21 TYPOAKWKONCBGF-UHFFFAOYSA-N 0.000 description 1
- LPUJPJKZOCHDPT-UHFFFAOYSA-N 6-hydroxy-n,n-dimethyl-5,6-dihydrobenzo[b][1]benzothiepine-3-sulfonamide Chemical compound OC1CC2=CC(S(=O)(=O)N(C)C)=CC=C2SC2=CC=CC=C21 LPUJPJKZOCHDPT-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Natural products OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 208000009132 Catalepsy Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 206010047853 Waxy flexibility Diseases 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 210000004227 basal ganglia Anatomy 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- QSKWJTXWJJOJFP-UHFFFAOYSA-N chloroform;ethoxyethane Chemical compound ClC(Cl)Cl.CCOCC QSKWJTXWJJOJFP-UHFFFAOYSA-N 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 230000009194 climbing Effects 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229960003280 cupric chloride Drugs 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 150000004292 cyclic ethers Chemical class 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- SBZXBUIDTXKZTM-UHFFFAOYSA-N diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- ZPAJPSXABASQNJ-UHFFFAOYSA-N ethyl 4-(3-bromo-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)piperazine-1-carboxylate Chemical compound C1CN(C(=O)OCC)CCN1C1C2=CC=CC=C2SC2=CC=C(Br)C=C2C1 ZPAJPSXABASQNJ-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000010655 horseradish oil Substances 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 150000002440 hydroxy compounds Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- TYQCGQRIZGCHNB-JLAZNSOCSA-N l-ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(O)=C(O)C1=O TYQCGQRIZGCHNB-JLAZNSOCSA-N 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000002763 monocarboxylic acids Chemical class 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- GEVPUGOOGXGPIO-UHFFFAOYSA-N oxalic acid;dihydrate Chemical compound O.O.OC(=O)C(O)=O GEVPUGOOGXGPIO-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- ZLMJMSJWJFRBEC-OUBTZVSYSA-N potassium-40 Chemical compound [40K] ZLMJMSJWJFRBEC-OUBTZVSYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000000859 sublimation Methods 0.000 description 1
- 230000008022 sublimation Effects 0.000 description 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- BISQTCXKVNCDDA-UHFFFAOYSA-N thiepine Chemical compound S1C=CC=CC=C1 BISQTCXKVNCDDA-UHFFFAOYSA-N 0.000 description 1
- HFRXJVQOXRXOPP-UHFFFAOYSA-N thionyl bromide Chemical compound BrS(Br)=O HFRXJVQOXRXOPP-UHFFFAOYSA-N 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Description
Nærværende oppfinnelse vedrører fremstillingen av tri- The present invention relates to the production of tri-
cykliske forbindelser av den generelle formel cyclic compounds of the general formula
R^ betyr halogen, lavere alkyl, R^ means halogen, lower alkyl,
X oksygen, lavere alkylimino eller metylen, X oxygen, lower alkylimino or methylene,
m tallet 0 eller 1, —^m the number 0 or 1, —^
R og R^ betyr hydrogen eller sammen gruppen Js<*>R and R^ mean hydrogen or together the group Js<*>
og salter av disse forbindelser. and salts of these compounds.
Uttrykket "lavere alkyl" alene eller sammen med andre grupper The term "lower alkyl" alone or together with other groups
betyr alifatiske rester med 1 til 6 karbonatomer, means aliphatic residues with 1 to 6 carbon atoms,
som kan være rettkjedede eller forgrenede. Eksempler på which can be straight chain or branched. Examples of
slike grupper er metyl, etyl, isopropyl, n-heksyl osv. such groups are methyl, ethyl, isopropyl, n-hexyl, etc.
"Halogen" er alle 4 halogenatomene, dvs» fluor, klor, brom og jod. Klor er foretrukket„ "Halogen" is all 4 halogen atoms, i.e. fluorine, chlorine, bromine and iodine. Chlorine is preferred
Det er blitt funnet at forbindelsene med formel I ifolge oppfinnelsen og deres salter, som er nye forbindelser, utmerker seg ved sterke sentraldempende og neuroleptiske egenskaper. De kan dermed f0eks0 anvendes for behandling av akutt eller kronisk schizofreni så vel som også som beroligende midler. Særlig fordelaktig er at ingen eller bare svake kataleptiske bivirkninger opptrer, slik at ingen eller bare ubetydelige motoriske forstyrrelser merkes. Formel I omhandler kun de hydrogenerte forbindelser av forbindelser med formel IV It has been found that the compounds of formula I according to the invention and their salts, which are new compounds, are distinguished by strong central depressant and neuroleptic properties. They can therefore, for example, be used for the treatment of acute or chronic schizophrenia as well as also as sedatives. Particularly advantageous is that no or only weak cataleptic side effects occur, so that no or only negligible motor disturbances are felt. Formula I deals only with the hydrogenated compounds of compounds of formula IV
og deres salter. Særlig foretrukne forbindelser er 3-{2-[4-(2-klor-lO,11-dihydro-dibenzo[b,f]tiepin-10-yl)-1-piperazinyl]-etyl}- -2-oksazolidinon og 3- {2-[4-(lo,11-dihydro-2-metyl-dibenzo[b,f]tiepin-10-yl)-l-piperazinyl]etylj- -2-oksazolidinon såvel som deres salter. and their salts. Particularly preferred compounds are 3-{2-[4-(2-chloro-10,11-dihydro-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-ethyl}-2-oxazolidinone and 3 - {2-[4-(10,11-dihydro-2-methyl-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]ethyl j- -2-oxazolidinone as well as their salts.
Forbindelsene med den generelle formel I og deres salter fremstilles ifolge oppfinnelsen ved en fremgangsmåte som er karakterisert ved at man omsetter en forbindelse med formelen The compounds with the general formula I and their salts are prepared according to the invention by a method which is characterized by reacting a compound with the formula
der R-j^ har den ovenfor angitte betydning og Y er en av-gangsgruppe med en forbindelse med formelen der m, R2, R3 og X har den ovenfor angitte betydning, eller at man reduserer en forbindelse med formelen where R-j^ has the meaning given above and Y is a leaving group with a compound of the formula where m, R2, R3 and X have the meaning given above, or that one reduces a compound of the formula
hvor m, R-, , R-, R og X har den ovenfor angitte betydning, where m, R-, , R-, R and X have the above meaning,
J- £• 3J- £• 3
eller at man omsetter en forbindelse med formelen or that one reacts a compound with the formula
der R1 har den ovenfor angitte betydning, med en forbindelse med formelen where R 1 has the meaning given above, with a compound of the formula
hvor X, Y, m, R2 og R3 har den ovenfor angitte betyd- where X, Y, m, R2 and R3 have the above-mentioned meaning
ning, og om ønsket overføre det erholdte produkt i et salt. ning, and if desired transfer the obtained product into a salt.
Den uttredende gruppe Y av utgangsforbindelsene med formel The outgoing group Y of the outgoing compounds of formula
II er fortrinnsvis halogen eller alkyl- henholdsvis aryl-substituert sulfonyloksy. I gruppen Y av utgangsforbindelsene med formel II tilstedeværende alkylgrupper henholdsvis aryl-grupper er fortrinnsvis lavere grupper, særlig metyl henholdsvis fenyl eller tolyl; tilstedeværende halogenatomer er fortrinnsvis klor eller brom. II is preferably halogen or alkyl- or aryl-substituted sulfonyloxy. In the group Y of the starting compounds with formula II, the alkyl groups or aryl groups present are preferably lower groups, especially methyl or phenyl or tolyl; halogen atoms present are preferably chlorine or bromine.
Utgangsforbindelsene med formel II er kjente forbindelser eller analoge til kjente forbindelser, hvilke lar seg fremstille etter kjente metoder. F.eks. innfores gruppen Y i dens forskjellige betydninger på folgende måte: Y = halogen: Den tilsvarende 10-hydroksyforbindelse omsettes med et egnet halogenid, f„eks. tionylklorid, tionylbromid, eller med et hydrohalogenid i nærvær av et vannbindende middel, som klorhydrogen og kalsiumklorid. The starting compounds of formula II are known compounds or analogues of known compounds, which can be prepared according to known methods. E.g. the group Y is introduced in its various meanings as follows: Y = halogen: The corresponding 10-hydroxy compound is reacted with a suitable halide, e.g. thionyl chloride, thionyl bromide, or with a hydrohalide in the presence of a water binding agent, such as hydrogen chloride and calcium chloride.
Y = alkyl- henholdsvis aryl-substituert sulfonyloksy: Den tilsvarende 10-hydroksyforbindelse omsettes med et alkyl-henholdsvis aryl-substituert sulfonsyrehalogenid, f.eks. kloridet. Y = alkyl- or aryl-substituted sulfonyloxy: The corresponding 10-hydroxy compound is reacted with an alkyl- or aryl-substituted sulfonic acid halide, e.g. the chloride.
Utgangsforbindelsene med formel III kan f.eks. fremstilles etter folgende reaksjonsligning: The starting compounds of formula III can e.g. is produced according to the following reaction equation:
I foranstående reaksjonsligning har X, Y, m, og R^In the above reaction equation, X, Y, m, and R^ have
de foran angitte betydninger og betyr en egnet beskyttelsesgruppe, for eksempel benzyl eller en lavere alkoksykarbonyl-gruppe, for eksempel metoksykarbonyl, etoksykarbonyl. Konden-sasjonen skjer fortrinnsvis i nærvær av et syrebindende middel, for eksempel kaliumkarbonat eller trietylamin. Til slutt fjernes beskyttelsesgruppen, benzylgruppen ved hydrogenolyse, alkoksykarbonylgruppen for eksempel ved alkalisk hydro- the above meanings and means a suitable protecting group, for example benzyl or a lower alkoxycarbonyl group, for example methoxycarbonyl, ethoxycarbonyl. The condensation preferably takes place in the presence of an acid-binding agent, for example potassium carbonate or triethylamine. Finally, the protecting group, the benzyl group, is removed by hydrogenolysis, the alkoxycarbonyl group, for example, by alkaline hydro-
lyse. bright.
Omsetningen ifolge oppfinnelsen av utgangsf orbindelsene av formlene II og III skjer hensiktsmessig i et inert organisk opplosningsmiddel, f.eks. i et aromatisk hydrokarbon, f.eks. benzen eller toluen, i et klorert hydrokarbon, f.eks. metylenklorid, trikloretylen, kloroform, karbontetraklorid eller klorbenzen, i en alifatisk eller cyklisk eter, som dietyleter, tetrahydrofuran eller dioksan eller også i dimetylformamid eller dimetylsulfoksyd. Temperaturen ligger hensiktsmessig mellom ca. 30 og 200°C, hvorved det fortrinnsvis arbeides ved temperaturer i området omkring 100°C. Hvis en utgangsforbindelse av formel II anvendes, hvor Y er halogen eller alkyl- henholdsvis arylsubstituert sulfonyloksy, gjennomføres omsetningen fortrinnsvis i nærvær av et syrebindende middel, fortrinnsvis i nærvær av et alkalikarbonat, f.eks. kaliumkarbonat, eller også i nærvær av et overskudd av utgangsforbindelsen av formel The reaction according to the invention of the starting compounds of the formulas II and III conveniently takes place in an inert organic solvent, e.g. in an aromatic hydrocarbon, e.g. benzene or toluene, in a chlorinated hydrocarbon, e.g. methylene chloride, trichloroethylene, chloroform, carbon tetrachloride or chlorobenzene, in an aliphatic or cyclic ether, such as diethyl ether, tetrahydrofuran or dioxane or also in dimethylformamide or dimethylsulfoxide. The temperature is suitably between approx. 30 and 200°C, whereby work is preferably done at temperatures in the region of around 100°C. If a starting compound of formula II is used, where Y is halogen or alkyl- or aryl-substituted sulfonyloxy, the reaction is preferably carried out in the presence of an acid-binding agent, preferably in the presence of an alkali carbonate, e.g. potassium carbonate, or also in the presence of an excess of the starting compound of formula
III. III.
Reduksjonen ifolge oppfinnelsen av enaminet av formel IV skjer fortrinnsvis ved behandling med et alkalimetallborhydrid i nærvær av en sterk syre. Som alkalimetallborhydrid anvendes fortrinnsvis natrium- eller kaliumborhydrid, særlig natriumborhydrid. Litiumborhydrid kan også likeledes anvendes. Den sterke syre kan såvel være en organisk som også en uorganisk syre. Som organiske syrer kommer i betraktning rettkjedede eller forgrenede, lavere mono- eller dikarboksylsyrer med inntil 4 karbonatomer, som kan være halogensubstituerte, som f.eks. maursyre, eddiksyre, trikloreddiksyre, trifluoreddik-syre, propionsyre, isosmbrsyre, oksalsyre og lignende. The reduction according to the invention of the enamine of formula IV takes place preferably by treatment with an alkali metal borohydride in the presence of a strong acid. The alkali metal borohydride used is preferably sodium or potassium borohydride, in particular sodium borohydride. Lithium borohydride can also be used. The strong acid can be an organic as well as an inorganic acid. As organic acids, straight-chain or branched, lower mono- or dicarboxylic acids with up to 4 carbon atoms, which may be halogen-substituted, such as e.g. formic acid, acetic acid, trichloroacetic acid, trifluoroacetic acid, propionic acid, isosmbric acid, oxalic acid and the like.
Foretrukket er eddiksyre, særlig foretrukket er oksalsyre. Acetic acid is preferred, oxalic acid is particularly preferred.
Som uorganiske syrer kommer særlig i betraktning: Svovelsyre, halogenhydrogensyre, særlig klorhydrogensyre eller lignende. As inorganic acids, particularly come into consideration: Sulfuric acid, hydrohalic acid, especially hydrochloric acid or the like.
En foretrukket uorganisk syre er konsentrert svovelsyre. A preferred inorganic acid is concentrated sulfuric acid.
Da enaminet av formel IV er ubestandig i nærvær av vann, gjennomfores reduksjonen hensiktsmessig i fravær av vann; det anvendes hensiktsmessig bare vannfrie syrer henholdsvis bare Since the enamine of formula IV is unstable in the presence of water, the reduction is conveniently carried out in the absence of water; it is appropriate to use only anhydrous acids or only
slike syrer, ved hvilke, hvis de inneholder noe vann, dette such acids, by which, if they contain any water, this
ikke avgis, som f.eks. konsentrert svovelsyre. Omsetningen med et alkalimetallborhydrid og en sterk syre gjennomfores med fordel i en eter, som dietyleter, tetrahydrofuran, dioksan, dietylenglykol-dimetyleter, (diglymer) eller dimetoksyetan, såvel som ved en temperatur mellom romtemperatur og opplosnings— middelets tilbakelopstemperatur. Fortrinnsvis arbeider man under tilbakelopsbetingelser. Reduksjonen ifolge oppfinnelsen av enaminene av formel IV kan også gjennomfores etter andre metoder, for eksempel ved behandling med maursyre eller sink og iseddik. Også disse omsetninger gjennomfores fortrinnsvis ved en temperatur mellom romtemperatur og opplosningsmiddelets tilbakelopstemperatur, fortrinnsvis ved tilbakelbpstemperaturen. Ved reduksjon med sink og iseddik reduseres en tilstedeværende nitrogruppe R^ langtgående til aminogruppen. not issued, such as concentrated sulfuric acid. The reaction with an alkali metal borohydride and a strong acid is advantageously carried out in an ether, such as diethyl ether, tetrahydrofuran, dioxane, diethylene glycol dimethyl ether, (diglymer) or dimethoxyethane, as well as at a temperature between room temperature and the reflux temperature of the solvent. Preferably, you work under backflow conditions. The reduction according to the invention of the enamines of formula IV can also be carried out by other methods, for example by treatment with formic acid or zinc and glacial acetic acid. These reactions are also preferably carried out at a temperature between room temperature and the reflux temperature of the solvent, preferably at the reflux temperature. By reduction with zinc and glacial acetic acid, a present nitro group R^ is reduced extensively to the amino group.
Utgangsforbindelsene av formel V kan f.eks. fremstilles ved omsetning av en forbindelse med formel II med et mono-N-beskyttet piperazin, f.eks. N-karbetoksypiperazin, Kondensa-sjon sprodukt et forsåpes deretter alkalisk, f.eks. ved hjelp av vandig alkali. The starting compounds of formula V can e.g. is prepared by reacting a compound of formula II with a mono-N-protected piperazine, e.g. N-carbethoxypiperazine, Condensation product is then saponified alkaline, e.g. using aqueous alkali.
Den i utgangsforbindelsene av formel VI tilstedeværende uttredende gruppe har den samme betydning som i tilfelle av de foran beskrevne utgangsforbindelser med formel II. Utgangsforbindelsene av formel VI kan f.eks. fremstilles på den måte at man omdanner et laktam av formelen The leaving group present in the starting compounds of formula VI has the same meaning as in the case of the starting compounds of formula II described above. The starting compounds of formula VI can e.g. is produced in such a way that a lactam of the formula is converted
hvor m, R2, og X har foran angitte betydninger, where m, R2, and X have the above meanings,
til det tilsvarende alkalimetallsalt, f.eks. natriumsaltet. Dette kan f.eks. skje ved behandling av laktamet av formel X med et alkalimetallhydrid eller alkalimetallamid i et aromatisk hydrokarbon, som f.eks„ benzen, toluen eller dimetylformamid. Detetter omsettes det oppnådde alkalimetallsalt med en forbindelse av formel to the corresponding alkali metal salt, e.g. the sodium salt. This can e.g. occur by treating the lactam of formula X with an alkali metal hydride or alkali metal amide in an aromatic hydrocarbon, such as, for example, benzene, toluene or dimethylformamide. The resulting alkali metal salt is then reacted with a compound of formula
hvor Hal er halogen og where Hal is halogen and
Rj- er en egnet beskyttelsesgruppe, f.eks. benzyl Rj- is a suitable protecting group, e.g. benzyl
eller 2-tetrahydropyranyl, or 2-tetrahydropyranyl,
Be skyttel sesgruppen R,, i kondensasjonsproduktet spaltes deretter hydrogenolytisk henholdsvis hydrolytisk. Den oppnådde hydroksyforbindelse omsettes med et halogeneringsmiddel, The shuttle group R,, in the condensation product is then cleaved hydrogenolytically or hydrolytically. The obtained hydroxy compound is reacted with a halogenating agent,
f.eks. tionylklorid, eller med et alkyl- henholdsvis aryl-substituert sulfonsyrehalogenid, f.eks. kloridet, og man får da en utgangsforbindelse med formel VI. e.g. thionyl chloride, or with an alkyl- or aryl-substituted sulphonic acid halide, e.g. the chloride, and a starting compound with formula VI is then obtained.
Omsetningen ifolge oppfinnelsen av utgangsforbindelsene av formel V og VI skjer hensiktsmessig i et inert organisk opplosningsmiddel, f.eks. i et aromatisk hydrokarbon, f.eks. benzen eller toluen, et klorert hydrokarbon, f.eks. kloroform, en eter, f.eks. dioksan eller dimetoksyetan, en lavere alkanol, som metanol eller etanol, et keton, som aceton eller metyletylketon, eller også i dimetylformamid eller dimetylsulfoksyd. Det er foretrukket å gjennomfdre omsetningen i nærvær av et syrebindende middel, f.eks. i nærvær av et alkalimetallkarbonat, f.eks. natrium- eller kaliumkarbonat, eller i nærvær av en inert organisk base, f„eks. trietylamin. Som syrebindende middel kommer likeledes et overskudd av den anvendte base av formel V på tale. Temperaturen for omsetningen ligger fortrinnsvis i området mellom romtemperatur og reaksjonsblandingens kokepunkt. The reaction according to the invention of the starting compounds of formulas V and VI conveniently takes place in an inert organic solvent, e.g. in an aromatic hydrocarbon, e.g. benzene or toluene, a chlorinated hydrocarbon, e.g. chloroform, an ether, e.g. dioxane or dimethoxyethane, a lower alkanol, such as methanol or ethanol, a ketone, such as acetone or methyl ethyl ketone, or also in dimethylformamide or dimethylsulfoxide. It is preferred to carry out the reaction in the presence of an acid-binding agent, e.g. in the presence of an alkali metal carbonate, e.g. sodium or potassium carbonate, or in the presence of an inert organic base, e.g. triethylamine. As an acid-binding agent, an excess of the used base of formula V also comes into question. The temperature for the reaction is preferably in the range between room temperature and the boiling point of the reaction mixture.
Oppnådde baser av formel I danner salter såvel med uorganiske som også med organiske syrer, f.eks. med halogenhydrogensyrer, som klorhydrogensyre , bromhydrogensyre eller jodhydrogen-syre, med andre mineralsyrer, som svovelsyre, fosforsyre eller salpetersyre, samt med organiske syrer, som vinsyre, citronsyre, kamfersulfonsyre, etansulfonsyre, toluensulfonsyre, salicylsyre, ascorbinsyre, maleinsyre eller mandelsyre osv„ Foretrukne salter er hydrohalogenider, særlig hydrokloridene og maleatene. Syreaddisjonssaltene fremstilles fortrinnsvis i et egnet opplosningsmiddel, som etanol, aceton eller acetonitril ved behandling av frie baser med den tilsvarende, ikke-vandige syre. Obtained bases of formula I form salts both with inorganic and also with organic acids, e.g. with halogenated acids, such as hydrochloric acid, hydrobromic acid or hydroiodic acid, with other mineral acids, such as sulfuric acid, phosphoric acid or nitric acid, as well as with organic acids, such as tartaric acid, citric acid, camphorsulfonic acid, ethanesulfonic acid, toluenesulfonic acid, salicylic acid, ascorbic acid, maleic acid or mandelic acid, etc. Preferred salts are hydrohalides, especially the hydrochlorides and maleates. The acid addition salts are preferably prepared in a suitable solvent, such as ethanol, acetone or acetonitrile by treating free bases with the corresponding, non-aqueous acid.
Basene med formel I er delvis krystallinske, faste substanser som er relativt godt opploselig i dimetylsulfoksyd, dimetylformamid eller i klorerte hydrokarboner, som f.eks. kloroform, metylenklorid eller også i alkanoler, som metanol eller etanol, og er relativt uopploselige i vann. The bases of formula I are partially crystalline, solid substances which are relatively well soluble in dimethylsulfoxide, dimethylformamide or in chlorinated hydrocarbons, such as e.g. chloroform, methylene chloride or also in alkanols, such as methanol or ethanol, and are relatively insoluble in water.
Syreaddisjonssaltene av basene med formel I er krystallinske, faste substanser. De er godt opploselige i dimetylsulfoksyd og dimetylformamid og i alkanoler, som metanol eller etanol, og delvis også i kloroform, metylenklorid og vann. De er relativt uopploselige i benzen, eter og petroleter. The acid addition salts of the bases of formula I are crystalline solids. They are well soluble in dimethylsulfoxide and dimethylformamide and in alkanols, such as methanol or ethanol, and partly also in chloroform, methylene chloride and water. They are relatively insoluble in benzene, ether and petroleum ether.
En kataleptisk virkning ('vekst-stivhet" t dvs. abnorm lang opprettholdelse av en påtvunget kroppsstilling) gjelder ved sentraldempende henholdsvis neuroleptisk virksomme forbindelser som en forstyrrende bivirkning og oppviser motoriske forstyrrelser. Produktene ifolge oppfinnelsen har den fordel at de ikke henholdsvis bare i meget liten grad har denne forstyrrende bivirkning. For påvisning av dette ble representative representanter av sluttproduktene administrert intraperitonalt til rotter. De folgende representanter ble provet: PRODUKT A: 3- {2-[4-(2-klor-lO,ll-dihydro-dibenzo[b,f]-tiepin-10-yl)-l-piperazinyl]-etyl} -2-oksazolidinon-maleat. A cataleptic effect ('growth stiffness' i.e. abnormally long maintenance of a forced body position) applies to centrally depressant or neuroleptically active compounds as a disturbing side effect and exhibits motor disturbances. The products according to the invention have the advantage that they do not or only in a very small degree this has a disturbing side effect. To demonstrate this, representative representatives of the end products were administered intraperitoneally to rats. The following representatives were tested: PRODUCT A: 3-{2-[4-(2-chloro-10,11-dihydro-dibenzo[ b,f]-Thiepin-10-yl)-1-piperazinyl]-ethyl}-2-oxazolidinone maleate.
PRODUKT B: 3- { l-[4-(10,ll-dihydro-2-metyl-dibenzo[b,f]-tiepin-10-yl)-l-piperazinyl]-etyl}- -2-oksazolidinon-maleat. PRODUCT B: 3-{1-[4-(10,11-dihydro-2-methyl-dibenzo[b,f]-thiepin-10-yl)-1-piperazinyl]-ethyl}-2-oxazolidinone maleate .
Som sammenligningssubstans ble klorpromazin, et anerkjent sentraldempende henholdsvis neuroleptisk middel, trukket inn. As a comparison substance, chlorpromazine, a recognized central depressant or neuroleptic, was included.
Dyrene gjelder som kataleptiske, når de homolaterale ekstremiteter forblir i krysset stilling i minst 10 sek. Antallet kataleptiske dyr noteres hvert 30 minutt i 6 timer. ED^0 er dosen ved hvilken 50% av dyrene viser katalepsi. The animals are considered cataleptic when the homolateral extremities remain in a crossed position for at least 10 seconds. The number of cataleptic animals is recorded every 30 minutes for 6 hours. ED^0 is the dose at which 50% of the animals show catalepsy.
Resultater: Results:
Tabellen viser at ingen henholdsvis bare liten kataleptisk virkning foreligger ved A og B i motsetning til klorpromazin. The table shows that there is no or only a small cataleptic effect with A and B, in contrast to chlorpromazine.
For påvisning av de sentraldempende henholdsvis neuroleptiske egenskaper for sluttproduktene ble representative representanter underkastet de folgende prover: To demonstrate the central depressant and neuroleptic properties of the final products, representative representatives were subjected to the following tests:
I. Roterende stav- prove I. Rotating rod test
Ved den roterende stav-prbve undersokes evnen hos mus til å fullfore en korodinert, motorisk ytelse. Mus anbringes etter peroral administrasjon av provesubstansen på en horisontal langsomt roterende stav og tiden inntil nedfall måles. The rotating rod test examines the ability of mice to complete a coordinated motor performance. After oral administration of the test substance, mice are placed on a horizontal slowly rotating rod and the time until precipitation is measured.
ED 50 er den dose som reduserer oppholdstiden overfor den fo'r administrasjon av provesubstansen med 50%. ED 50 is the dose that reduces the residence time compared to that before administration of the test substance by 50%.
Produkt A viser ved denne prove en sterk virkning Product A shows a strong effect in this test
(ED 50 = 7, 9 mg/kg), som omtrent er lik med den for klorpromazin (ED 50 = 5 mg/kg) (ED 50 = 7.9 mg/kg), which is approximately equal to that of chlorpromazine (ED 50 = 5 mg/kg)
II, Bestemmelse av homovanillinsvre II, Determination of homovanillin acid
Rotter besproytes 2 timer for de drepes med provesubstansen. Homovanillinsvre ekstraheres f ra det som står over hjernehomogenat i butylacetat og senere i en vandig opplosning og oksyderes med kaliumferricyanid til en fluorescerende dimer. Fra den forhoyede konsentrasjon av homovanillinsyre (HVS) kan man slutte at provesubstansen virker som klorpromazin, dvs. den oker "turn over" av dopamin i basal-gangliene. Homovanillin-syretiteret hos ubehandlede rotter fastlegges vilkårlig til 100%. Rats are sprayed 2 hours before they are killed with the test substance. Homovanillic acid is extracted from the brain homogenate supernatant in butyl acetate and later in an aqueous solution and oxidized with potassium ferricyanide to a fluorescent dimer. From the increased concentration of homovanillic acid (HVS), one can conclude that the test substance acts like chlorpromazine, i.e. it increases the "turnover" of dopamine in the basal ganglia. The homovanillic acid titer in untreated rats is arbitrarily set at 100%.
Ved denne prove viser A og B en virkning som nesten kommer opp mot den for klorpromazin. In this test, A and B show an effect that almost matches that of chlorpromazine.
III. " Stang- klatre" prove III. "Pole climb" test
Proven gir opplysning om adferdsreaksjoner hos rotter. Rotter trenes ved oppklatring på en vertikal stang i forsokskammeret til å unngå den noen sekunder etter et akustisk signal The test provides information on behavioral reactions in rats. Rats are trained by climbing a vertical bar in the test chamber to avoid it a few seconds after an acoustic signal
(kondisjonert irritasjon) via gulvgitter utloste elektriske irritasjon (ukondisjohert irritasjon) . (conditioned irritation) triggered electrical irritation (unconditioned irritation) via the floor grid.
Hemmingen av den kondisjonerte reaksjon bestemmes ved parameteret ED 50 (mg/kg p.o.) og hemmingen av den ukondisjonerte reaksjon ved parameteret ED 10 (mg/kg p.o,). The inhibition of the conditioned reaction is determined by the parameter ED 50 (mg/kg p.o.) and the inhibition of the unconditioned reaction by the parameter ED 10 (mg/kg p.o,).
Parameteret ED 50 (hemming av den kondisjonerte reaksjon) gir et mål for den neuroleptiske virkningsstyrke for provesubstansen. Kvotienten ED 10 (hemming av den ukondisjonerte reaksjon)/ ED 50 (hemming av den konsisjonerte reaksjon) gir et mål for virkningskvaliteten for provesubstansen, idet ved stigende kvotient en storre selektivitet av den neuroleptiske virkning (mindre neurotoksisk bivirkning) foreligger The parameter ED 50 (inhibition of the conditioned reaction) gives a measure of the neuroleptic potency of the test substance. The quotient ED 10 (inhibition of the unconditioned reaction)/ ED 50 (inhibition of the conditioned reaction) gives a measure of the quality of action for the test substance, as with a rising quotient a greater selectivity of the neuroleptic effect (less neurotoxic side effect) is present
En sammenligning mellom produkt A og klorpromazin gir: A comparison between product A and chlorpromazine gives:
Ved denne prove viser A såvel en neuroleptisk virkningsstyrke som også en kvalitet (selektivitet) for den neuroleptiske virkning som overstiger den for klorpromazin. In this test, A shows both a neuroleptic potency and a quality (selectivity) for the neuroleptic effect that exceeds that of chlorpromazine.
Produktene ifolge oppfinnelsen kan finne anvendelse som lege-midler, f.eks. i form av farmasoytiske preparater som inneholder disse eller deres salter i blanding med et for den enterale, f.eksQ orale eller parenterale"administrasjon egnet farmasoytisk, organisk eller uorganisk inert bærer-materiale, som f.eks. vann, gelatin, melkesukker, stivelse, magnesiumstearat, talkum, planteolje, Gummi arabicum, poly-alkylenglykol, vaselin, osv. De farmasoytiske preparater kan foreligge i fast form, f.eks. som tabletter, dragéer, suppositorier, kapsler eller i flytende form, f.eks. som opplosninger, suspensjoner eller emulsjoner. Eventuelt er de sterilisert og/eller inneholder hjelpestoffer, som konser-verings-, stabiliserings-, fuktnings- eller emulgeringsmiddel, salter til forandring av det osmotiske trykk eller puffere. De kan også inneholde andre terapeutisk verdifulle stoffer. The products according to the invention can be used as pharmaceuticals, e.g. in the form of pharmaceutical preparations containing these or their salts in admixture with a pharmaceutical organic or inorganic inert carrier material suitable for enteral, e.g. oral or parenteral administration, such as water, gelatin, milk sugar, starch , magnesium stearate, talc, vegetable oil, gum arabic, poly-alkylene glycol, petroleum jelly, etc. The pharmaceutical preparations can be in solid form, e.g. as tablets, dragees, suppositories, capsules or in liquid form, e.g. as solutions , suspensions or emulsions. They may be sterilized and/or contain auxiliary substances, such as preservatives, stabilisers, wetting agents or emulsifiers, salts to change the osmotic pressure or buffers. They may also contain other therapeutically valuable substances.
Hensiktsmessig farmasoytisk doseringsform inneholder ca. Appropriate pharmaceutical dosage form contains approx.
1 til -200 mg av en forbindelse av formel I, henholdsvis en av dens salter. Hensiktsmessige orale doserings- 1 to -200 mg of a compound of formula I, respectively one of its salts. Appropriate oral dosage
områder ligger ved ca. 0,1 mg/kg pr. dag til ca. 7,5 mg/kg pr. dag. Hensiktsmessige parenterale doseringsområder -ligger ved ca. 0,Ol mg/kg pr. dag til ca. 0,75 mg/kg pr. dag. De nevnte områder kan imidlertid utvides oppover eller nedover alt etter de individuelle behov og fagmannens forskrifter. areas are located at approx. 0.1 mg/kg per day to approx. 7.5 mg/kg per day. Appropriate parenteral dosing ranges - are at approx. 0.Ol mg/kg per day to approx. 0.75 mg/kg per day. However, the areas mentioned can be extended upwards or downwards according to individual needs and the professional's regulations.
I de folgende eksempler er alle temperaturer angitt i Celsius-grader. In the following examples, all temperatures are given in degrees Celsius.
EKSEMPEL 1 EXAMPLE 1
2,7 g l-(10,ll-dihydro-2-metyldibenzo[b,f]tiepin-lO-yl)-piperazin tilsettes sammen med 4,3 g pulverisert kalium-. karbonat, 200 mg KJ og 90 ml toluen til 3,2 g N- ((3-kloretyl) oksazolidinon og oppvarmes 24 timer under tilbakelopskjoling. Derpå helles det på isvann, fortynnes det med benzen og den organiske fase vaskes med mettet sodaopplosning og vann, torkes med natriumsulfat og konsentreres under redusert trykk. Man får 3-[2-[4-(10,ll-dihydro-2-metyl-dibenzo[b,fjtiepin^lO-yl)-l-piperazinyl]-etyl]-2-oksazolidinon som omkrystalliseres fra aceton-petroleter. Maleatet smelter ved 159-161°. 2.7 g of 1-(10,11-dihydro-2-methyldibenzo[b,f]thiepin-10-yl)-piperazine are added together with 4.3 g of powdered potassium-. carbonate, 200 mg of KJ and 90 ml of toluene to 3.2 g of N-((3-chloroethyl)oxazolidinone and heated for 24 hours under reflux. It is then poured into ice water, diluted with benzene and the organic phase is washed with saturated soda solution and water , dried with sodium sulfate and concentrated under reduced pressure. 3-[2-[4-(10,11-dihydro-2-methyl-dibenzo[b,fthiepin^10-yl)-1-piperazinyl]-ethyl]- 2-Oxazolidinone which is recrystallized from acetone-petroleum ether The maleate melts at 159-161°.
Det som utgangsmateriale anvendte 1-(10,ll-dihydro-2-metyl-dibenzo[b,f]tiepin-10-yl)-piperazin kan fremstilles som folger: 20 g 5-metylantranilsyre suspenderes i 200 ml 3N saltsyre ved 0°. Til dette setter man dråpevis under omroring en opplosning på IO g natriumnitrit og 20 ml vann og rorer om 25 minutter ved 0°.* Ved 5-10° tilsetter man derpå dråpevis en opplosning på 26,5 g kaliumjodid, 30 ml 3N saltsyre og 30 ml vann. The 1-(10,11-dihydro-2-methyl-dibenzo[b,f]thiepin-10-yl)-piperazine used as starting material can be prepared as follows: 20 g of 5-methylanthranilic acid are suspended in 200 ml of 3N hydrochloric acid at 0° . To this, a solution of 10 g of sodium nitrite and 20 ml of water is added dropwise while stirring and stirred for 25 minutes at 0°.* At 5-10°, a solution of 26.5 g of potassium iodide, 30 ml of 3N hydrochloric acid and 30 ml of water.
Man rorer videre om 30 minutter ved romtemperatur og 2 timer ved tilbakelopskjoling. Man avkjoler, tilfdyer natriumtio-sulfat inntil reaksjonsopplosningen er gul (5 g) og nutsjer den oppnådde krystallinske 2-jod-5-metyl-benzoesyre av og vasker med vann inntil noytral. Den rå syre opploses i eter, vaskes godt med natriumtiosulfatopplosning og vann, torkes over natriumsulfat og dampes inn. Man oppnår lysebrune krystaller med smp. 100-112°. Stirring continues for 30 minutes at room temperature and 2 hours at reflux. It is cooled, sodium thiosulphate is added until the reaction solution is yellow (5 g) and the crystalline 2-iodo-5-methyl-benzoic acid obtained is filtered off and washed with water until neutral. The crude acid is dissolved in ether, washed well with sodium thiosulphate solution and water, dried over sodium sulphate and evaporated. Light brown crystals with m.p. 100-112°.
Til en opplosning av 855 g kaliumhydroksyd i 7 1 vann tilsetter man ved 50° under argon 420 g tiofenol og rorer om i 15 min. Derpå tilsetter man 22,1 g kobberpulver og 1 kg 2-jod-5-metyl-benzoesyre og oppvarmer 7 timer ved tilbakelopskjoling. Etter avkjoling innstilles med 600 ml konsentrert saltsyre på pH 3 og ekstraheres med metylenklorid, vaskes med vann, torkes over natriumsulfat og konsentreres inntil en tykk krystallgrot. Deretter nutsjes det av, vaskes med kald etanol og lavtkokende petroleter og torkes. Man får 3-metyl-6-(fenyltio)-benzoe- To a solution of 855 g of potassium hydroxide in 7 l of water, 420 g of thiophenol are added at 50° under argon and stirred for 15 min. 22.1 g of copper powder and 1 kg of 2-iodo-5-methyl-benzoic acid are then added and heated for 7 hours at reflux. After cooling, adjust to pH 3 with 600 ml of concentrated hydrochloric acid and extract with methylene chloride, wash with water, dry over sodium sulphate and concentrate to a thick crystal mass. It is then scraped off, washed with cold ethanol and low-boiling petroleum ether and dried. 3-methyl-6-(phenylthio)-benzoe-
syre med smp. 156-157°. acid with m.p. 156-157°.
650 g 3-metyl-6-(fenyltio)-benzosyre i 7,5 1 absolutt metanol tilsettes langsomt 300 ml konsentrert svovelsyre og oppvarmes i 24 timer ved tilbakelopskjoling. Man konsentrerer og heller resten på en isavkjolt natriumbikarbonatopplosning. Det hele ekstraheres med eter, vaskes med vann, torkes over natriumsulf at og konsentreres. Man får 3-metyl-6-(fenyltio)-ben-zosyremetylester som rodbrun olje, som krystalliserer ved hen-stand. 650 g of 3-methyl-6-(phenylthio)-benzoic acid in 7.5 1 of absolute methanol is slowly added to 300 ml of concentrated sulfuric acid and heated for 24 hours by refluxing. The residue is concentrated and poured onto an ice-cooled sodium bicarbonate solution. The whole is extracted with ether, washed with water, dried over sodium sulphate and concentrated. 3-Methyl-6-(phenylthio)-benzoic acid methyl ester is obtained as a red-brown oil, which crystallizes on standing.
322,5 g 3-metyl-6-(fenyltio)-benzosyremetylester i 3 1 absolutt tetrahydrofuran tilsettes dråpevis under argon og tilbakelopskjoling 420 ml av en 70 %'s natrium-dihydro-bis(2-metoksyetoksy)-aluminatopplosning i benzen (30 minutter) og kokes ytterligere 3 timer ved tilbakelopskjoling. Derpå kjoler man av til ca. 4°, fortynner med 1 liter benzen og hrydrolyserer med 700 ml 2N saltsyre, heller derpå på isvann og tilsetter ytterligere 400 322.5 g of 3-methyl-6-(phenylthio)-benzoic acid methyl ester in 3 1 of absolute tetrahydrofuran are added dropwise under argon and under reflux to 420 ml of a 70% sodium dihydro-bis(2-methoxyethoxy)-aluminate solution in benzene (30 minutes) and cook for a further 3 hours by refluxing. Then you undress for approx. 4°, dilute with 1 liter of benzene and hydrolyze with 700 ml of 2N hydrochloric acid, then pour onto ice water and add a further 400
ml konsentrert saltsyre for å få en klar opplosning. Den organiske fase vaskes med vann, torkes over natriumsulfat, filtreres og dampes inn. Man får 3-metyl-6-(fenyltio)-benzylalkohol som rodbrun olje. ml of concentrated hydrochloric acid to obtain a clear solution. The organic phase is washed with water, dried over sodium sulphate, filtered and evaporated. 3-methyl-6-(phenylthio)-benzyl alcohol is obtained as a red-brown oil.
570,7 g metyl-6-(fenyltio)-benzylalkohol opploses i 1,5 1 benzen og oppvarmes ved tilbakelopskjoling. Til denne tilsetter man dråpevis i lopet av 45 minutter 352 ml tionylklorid og koker videre i 90 minutter. Derpå konsentrerer man under redusert trykk og får 3-metyl-6-(fenyltio)-benzylklorid som rodbrun olje. 570.7 g of methyl-6-(phenylthio)-benzyl alcohol are dissolved in 1.5 l of benzene and heated at reflux. To this, 352 ml of thionyl chloride is added drop by drop over the course of 45 minutes and boiled for 90 minutes. It is then concentrated under reduced pressure and 3-methyl-6-(phenylthio)-benzyl chloride is obtained as a red-brown oil.
194 g kaliumcyanid i 250 ml vann oppvarmes i en argonatmosfære i 17 timer ved tilbakelopskjoling med 616,9 g 3-metyl-8-(fenyl-tio) -benzylklorid i 900 ml etanol. Deretter destilleres etanolen av under redusert trykk, derpå fortynnes med vann og ekstraheres med eter. Ekstraktene vaskes med vann, torkes over natriumsulfat og dampes inn. Man får 3-metyl-6-(fenyltio)-fe-nylacetonitril som en olje. 194 g of potassium cyanide in 250 ml of water are heated in an argon atmosphere for 17 hours by refluxing with 616.9 g of 3-methyl-8-(phenyl-thio)-benzyl chloride in 900 ml of ethanol. The ethanol is then distilled off under reduced pressure, then diluted with water and extracted with ether. The extracts are washed with water, dried over sodium sulphate and evaporated. 3-Methyl-6-(phenylthio)-phenylacetonitrile is obtained as an oil.
500 g 3-metyl-6-(fenyltio)-fenylacetonitril, 1,2 1 etanol, 470 g kaliumhydroksyd og 500 rnl vann oppvarmes 12 timer ved tilbakelopskjoling. Derpå dampes etanolen av under redusert trykk. Resten tilsettes vann inntil fullstendig opplosning og de noytrale deler trekkes ut med benzen. Den vandige opplosning filtreres under tilsetning av noe dikalitt og aktivt kull, kjoles og innstilles med konsentrert saltsyre på pH 3. Man ekstraherer derpå med 3x1 liter kloroform, vasker med vann, torker med kalsiumklorid, filtrerer og konsentrerer under redusert trykk. Den oppnådde rå 3-metyl-6-(fenyltio)-fenyl-eddiksyre omkrystalliseres fra benzen-heksan. Smp. 132-135° 500 g of 3-methyl-6-(phenylthio)-phenylacetonitrile, 1.2 l of ethanol, 470 g of potassium hydroxide and 500 ml of water are heated for 12 hours by refluxing. The ethanol is then evaporated under reduced pressure. Water is added to the residue until complete dissolution and the neutral parts are extracted with benzene. The aqueous solution is filtered with the addition of some dicalite and activated charcoal, cooled and adjusted with concentrated hydrochloric acid to pH 3. Extraction is then made with 3x1 liters of chloroform, washed with water, dried with calcium chloride, filtered and concentrated under reduced pressure. The crude 3-methyl-6-(phenylthio)-phenylacetic acid obtained is recrystallized from benzene-hexane. Temp. 132-135°
192 g polyfosforsyre oppvarmes til 100° i en nitrogenatmosfære, tilsettes hurtig 20 g 3-metyl-6-(fenyltio)-fenyleddiksyre og rores om i 1 time ved 100-103°. Derpå heller man det hele på isvann og ekstraherer med eter. Ekstraktene vaskes etter hverandre med 2N natronlut og vann og torkes over natriumsulfat. Ved konsentrering begynner det oppnådde 10,ll-dihydro-2-metyl-dibenzo[b,f]tiepin-lO-on å krystallisere ut. Ved tilsetning av petroleter og avkjoling blir krystallisasjonen fullstendig. Smp. 83 - 84°. 192 g of polyphosphoric acid are heated to 100° in a nitrogen atmosphere, 20 g of 3-methyl-6-(phenylthio)-phenylacetic acid are quickly added and stirred for 1 hour at 100-103°. The whole is then poured into ice water and extracted with ether. The extracts are washed successively with 2N caustic soda and water and dried over sodium sulphate. Upon concentration, the obtained 10,11-dihydro-2-methyl-dibenzo[b,f]thiepin-10-one begins to crystallize out. Upon addition of petroleum ether and cooling, the crystallization becomes complete. Temp. 83 - 84°.
10 g l0.,ll-dihydro-2-metyldibenzo[b,f]tiepin-10-on opploses i 10 g of 10,11-dihydro-2-methyldibenzo[b,f]thiepin-10-one is dissolved in
lOO ml dioksan og tilsettes 3,2 g natriumborhydrid i 5 ml vann. Deretter rorer man om i 20 timer ved romtemperatur. Derpå konsentreres under redusert trykk og resten fordeles mellom eter og vann. Den eteriske opplosning vaskes med mettet koksaltopplosning, torkes over natriumsulfat og dampes inn. Man får l0,ll-dihydro-2-metyldibenzo[b,f]tiepin-lO-ol som farge-los olje. 10 g 10,11-dihydro-2-metyldibenzo[b,f]tiepin-10-ol, 100 ml absolutt benzen og 10 g fint pulverisert kalsiumklorid mettes ved romtemperatur med torr saltsyregass (ca. 2 timer) og rores derpå ytterligere om i 20 timer. Man suger deretter kalsium-kloridet av, vasker med kloroform og konsentrerer filtratet under redusert trykk. Man får 10-klor-10,11-dihydro-2-metyl-dibenzo [b,f]tiepin som gul olje, som krystalliserer ved hen-stand. lOO ml of dioxane and add 3.2 g of sodium borohydride in 5 ml of water. It is then stirred for 20 hours at room temperature. It is then concentrated under reduced pressure and the residue is distributed between ether and water. The ethereal solution is washed with saturated sodium chloride solution, dried over sodium sulphate and evaporated. 10,11-dihydro-2-methyldibenzo[b,f]thiepin-10-ol is obtained as a colorless oil. 10 g of 10,11-dihydro-2-methyldibenzo[b,f]thiepin-10-ol, 100 ml of absolute benzene and 10 g of finely powdered calcium chloride are saturated at room temperature with dry hydrochloric acid gas (approx. 2 hours) and then stirred further in 20 hours. The calcium chloride is then sucked off, washed with chloroform and the filtrate concentrated under reduced pressure. 10-chloro-10,11-dihydro-2-methyl-dibenzo [b,f]thiepine is obtained as a yellow oil, which crystallizes on standing.
19,7 g 10-klor-lO , 11-dihydro- 2-metyldibenz.o [b,f Jtiepin opplost i 100 ml kloroform oppvarmes sammen.ned 36,5 g 1-karbetoksypiperazin i 24 timer ved tilbakelopskjoling. Derpå konsentreres under redusert trykk og resten krystalliserer fra aceton-heksan. Man får 1-karbetoksy-4-(10,11-dihydro-2-metyldibenzo Lb,f]tiepin-10-yl)-piperazin med smp. 96 - 98°. 19.7 g of 10-chloro-10,11-dihydro-2-methyldibenz.o[b,f Jtiepine dissolved in 100 ml of chloroform are heated together with 36.5 g of 1-carbethoxypiperazine for 24 hours at reflux. It is then concentrated under reduced pressure and the residue crystallizes from acetone-hexane. One obtains 1-carbethoxy-4-(10,11-dihydro-2-methyldibenzo Lb,f]thiepin-10-yl)-piperazine with m.p. 96 - 98°.
5,4 g 1-karbetoksy-4-(10-11,dihydro-2-metyldibenzo[b,fJtiepin-10- yl)-piperazin, 80 ml etylenglykol, 4,64 g kaliumhydroksyd og 0,33 ml vann oppvarmes i lopet av 3/4 time til 160°. Derpå helles på vann, ekstraheres med eter, ekstraktene vaskes med mettet koksaltopplosning, torkes over natriumsulfat og dampes inn. Man får 1-(10,11-dihydro-2-metyldibenzo[b,fjtiepin-lO-yl)-piperazin som en olje. 5.4 g of 1-carbethoxy-4-(10-11,dihydro-2-methyldibenzo[b,fJthiepin-10-yl)-piperazine, 80 ml of ethylene glycol, 4.64 g of potassium hydroxide and 0.33 ml of water are heated in the of 3/4 hour to 160°. Water is then poured on, extracted with ether, the extracts are washed with saturated sodium chloride solution, dried over sodium sulphate and evaporated. 1-(10,11-dihydro-2-methyldibenzo[b,fthiepin-10-yl)-piperazine is obtained as an oil.
EKSEMPEL 2 EXAMPLE 2
7,8 g 1-(2-klor-10,ll-dihydro-dibenzo[b,f]tiepin-l0-yl)-piperazin tilsettes sammen med 11,6 g pulverisert kaliumkarbonat, 0,2 g KJ og 100 ml toluen 8,22 g N- ((3-kloretyl) oksazolidinon og oppvarmes i 22 timer ved tilbakelopskjoling. Deretter helles på vann og den organiske fase vaskes med mettet sodaopplosning og vann, torkes over natriumsulfat og konsentreres under redusert trykk. Man får rått flytende 3-[2-[4-(2-klor-10, 11- dihydro-dibenzo[b,fjtiepin-lO-yl)-1-piperazinyl]-etylJ-2-oksazolidinon. Maleatet fremstilles ved omsetning med maleinsyre i etanol-eter$ smp. 17 3 - 175°. 7.8 g of 1-(2-chloro-10,11-dihydro-dibenzo[b,f]thiepin-10-yl)-piperazine are added together with 11.6 g of powdered potassium carbonate, 0.2 g of KJ and 100 ml of toluene 8.22 g of N- ((3-chloroethyl) oxazolidinone and heated for 22 hours by refluxing. Water is then poured and the organic phase is washed with saturated soda ash solution and water, dried over sodium sulfate and concentrated under reduced pressure. Crude liquid 3 is obtained -[2-[4-(2-chloro-10, 11-dihydro-dibenzo[b,fthiepin-10-yl)-1-piperazinyl]-ethyl J-2-oxazolidinone. The maleate is produced by reaction with maleic acid in ethanol-ether $ mp 17 3 - 175°.
Det som utgangsmateriale anvendte 1-(2-klor-10,11-dihydro-dibenzo [b, f Jtiepin-10-yl) -piperazin kan fremstilles som folger : 100 g 2,10-diklor-l0,ll-dihydro-dibenzo[b,fJtiepin i 300 ml kloroform oppvarmes i 24 timer ved tilbakelopskjoling sammen med 18 2 g 1-karbetoksypiperazin. Deretter fortynnes med kloroform og vann. Den organiske fase vaskes flere ganger med vann og torkes over magnesiumsulfat. Derpå konsentreres under redusert trykk og resten krystalliserer fra aceton-heksan. Man får 1-karbetoksy-4-(2-klor-10,11-dihydro-dibenzo[b,f jtiepin-10-yl)-piperazin; smp. 92 - 93°. The 1-(2-chloro-10,11-dihydro-dibenzo[b,f Jthiepin-10-yl)-piperazine used as starting material can be prepared as follows: 100 g of 2,10-dichloro-10,11-dihydro-dibenzo [b,fJtiepine in 300 ml of chloroform is heated for 24 hours at reflux together with 18 2 g of 1-carbethoxypiperazine. Then dilute with chloroform and water. The organic phase is washed several times with water and dried over magnesium sulfate. It is then concentrated under reduced pressure and the residue crystallizes from acetone-hexane. 1-Carbethoxy-4-(2-chloro-10,11-dihydro-dibenzo[b,f jthiepin-10-yl)-piperazine is obtained; m.p. 92 - 93°.
110 g 1-karbetoksy-4- ( 2-klor-lO-ll, dihydro-dibenzo [_b, f jtiepin-10-yl)-piperazin, 1,5 1 etylenglykol, 104 g kaliumhydroksyd og 5,4 ml vann oppvarmes i lopet av 1 time til 160°. Derpå helles på vann og ekstraheres med kloroform. Dei organiske fase vaskes med vann, torkes over magnesiumsulfat og dampes inn. Man får 1-(2-klor-lO,11-dihydro-dibenzo[b,fJtiepin-10-yl)-piperazin som en olje. 110 g of 1-carbethoxy-4-(2-chloro-10-11,dihydro-dibenzo[_b,f jtiepin-10-yl)-piperazine, 1.5 l of ethylene glycol, 104 g of potassium hydroxide and 5.4 ml of water are heated in the course of 1 hour to 160°. Then pour on water and extract with chloroform. The organic phase is washed with water, dried over magnesium sulphate and evaporated. One obtains 1-(2-chloro-10,11-dihydro-dibenzo[b,fJthiepin-10-yl)-piperazine as an oil.
EKSEMPEL 3 EXAMPLE 3
16,5 g 1-[2-klor-10,11-dihydro-dibenzo[b,fJtiepin-10-ylj-piperazin rores sammen med 9,8 g 3-(3-klorpropyl)-2-oksazolidinon, 5,25 g natriumkarbonat og 0,75 g natriumjodid i 100 ml butanol i 15 timer ved tilbakelopstemperatur. Opplosningsmidlet dampes deretter av under redusert trykk, og resten fordeles mellom kloroform og vann. Den organiske fase vaskes med vann, torkes med natriumsulfat og dampes inn under redusert trykk. Resten avfarges i metanol med aktivt kull. Fra den filtrerte opplosning krystalliserer ved avkjoling 3-[3-[4-(2-klor-10,11-dihydro-dibenzo [b,fJtiepin-10-yl)-1-piperazinylJ-propyl]-2-oksazolidinon med smp. 136°. Det i aceton tilberedte maleat smelter ved 195 - 196°. 16.5 g of 1-[2-chloro-10,11-dihydro-dibenzo[b,fJthiepin-10-yl]-piperazine are stirred together with 9.8 g of 3-(3-chloropropyl)-2-oxazolidinone, 5.25 g of sodium carbonate and 0.75 g of sodium iodide in 100 ml of butanol for 15 hours at reflux temperature. The solvent is then evaporated under reduced pressure, and the residue is partitioned between chloroform and water. The organic phase is washed with water, dried with sodium sulphate and evaporated under reduced pressure. The remainder is decolorized in methanol with activated charcoal. From the filtered solution crystallizes on cooling 3-[3-[4-(2-chloro-10,11-dihydro-dibenzo [b,fJthiepin-10-yl)-1-piperazinyl]-propyl]-2-oxazolidinone with m.p. 136°. The maleate prepared in acetone melts at 195 - 196°.
EKSEMPEL 4 EXAMPLE 4
50 g 10-klor-lO,11-dihydro-2-nitro-dibenzo[b,fJtiepin og 140 g 3-[2-(1-piperazinyl)-etylJ-2-oksazolidinon holdes i 15 minutter ved 120°. Etter avkjoling fortynnes reaksjonsblandingen med 2N natriumhydroksyd og ekstraheres med etylacetat. Den organiske fase vaskes med vann inntil noytral reaksjon og ekstraheres med 2N vandig metansulfonsyre. Den vandige fase ekstraheres med etylacetat, derpå gjores den alkalisk og ekstraheres på ny med etylacetat. Den organiske fase vaskes med vann inntil noytral reaksjon, torkes over magnesiumsulfat og dampes inn under redusert trykk. Det oppnådde 3-[2-[4-(10,11-dihydro-2-nitro-dibenzo[b,fJtiepin-10-yl)-1-piperazinyl]-etyl]-2-oksazolidinon omkrystalliseres fra aceton; smp. 130 - 132°. Ved omsetning av basen med maleinsyre får man det tilsvarende maleat; smp. 185 - 187°. 50 g of 10-chloro-10,11-dihydro-2-nitro-dibenzo[b,f]thiepine and 140 g of 3-[2-(1-piperazinyl)-ethyl]-2-oxazolidinone are held for 15 minutes at 120°. After cooling, the reaction mixture is diluted with 2N sodium hydroxide and extracted with ethyl acetate. The organic phase is washed with water until the reaction is neutral and extracted with 2N aqueous methanesulfonic acid. The aqueous phase is extracted with ethyl acetate, then made alkaline and extracted again with ethyl acetate. The organic phase is washed with water until the reaction is neutral, dried over magnesium sulphate and evaporated under reduced pressure. The obtained 3-[2-[4-(10,11-dihydro-2-nitro-dibenzo[b,fJthiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone is recrystallized from acetone; m.p. 130 - 132°. By reacting the base with maleic acid, the corresponding maleate is obtained; m.p. 185 - 187°.
Det ovenfor anvendte 10-klor-lO,11-dihydro-2-nitro-dibenzo[b,fJ tiepin kan fremstilles som folger: En opplosning av 480 g 2-klor-5-nitro-benzaldehyd i 3,2 1 etanol tilsettes dråpevis i en nitrogenatmosfære ved 30-40° under omroring og i lopet av 4 timer en opplosning av 320 g tiofenol i 120 g natriumhydroksyd, 2 1 etanol og 440 ml vann. Reaksjonsblandingen rores ytterligere i 30 minutter^ed 60°, avkjoles derpå til 0° og filtreres. Man får rått, krystallinsk 3-nitro-6-(fenyltio)-benzaldehyd med smp. 96 -100°. The 10-chloro-10,11-dihydro-2-nitro-dibenzo[b,fJ thiepine used above can be prepared as follows: A solution of 480 g of 2-chloro-5-nitro-benzaldehyde in 3.2 1 ethanol is added dropwise in a nitrogen atmosphere at 30-40° with stirring and in the course of 4 hours a solution of 320 g of thiophenol in 120 g of sodium hydroxide, 2 1 of ethanol and 440 ml of water. The reaction mixture is further stirred for 30 minutes at 60°, then cooled to 0° and filtered. Crude, crystalline 3-nitro-6-(phenylthio)-benzaldehyde with m.p. 96 -100°.
450 g 3-nitro-6-(fenyltio)-benzaldehyd suspenderes i 4 1 etanol og tilsettes porsjonsvis 111 g natriumborhydrid. Reaksjonsblandingen rores ytterligere 6 timer. Det hele fortynnes med 4 1 vann og ekstraheres med eter. Den organiske opplosning vaskes 450 g of 3-nitro-6-(phenylthio)-benzaldehyde are suspended in 4 l of ethanol and 111 g of sodium borohydride are added in portions. The reaction mixture is stirred for a further 6 hours. The whole is diluted with 4 1 of water and extracted with ether. The organic solution is washed
etter hverandre med vann og vandig natriumbikarbonatopplosnirig, torkes over magnesiumsulfat og dampes inn under redusert trykk. Det rå produkt omkrystalliseres fra benzen-petroleter. Man får 3-nitro-6-(fenyltio)-benzylalkohol; $mp. 104 - 107°. successively with water and aqueous sodium bicarbonate solvent, dried over magnesium sulfate and evaporated under reduced pressure. The crude product is recrystallized from benzene-petroleum ether. 3-nitro-6-(phenylthio)-benzyl alcohol is obtained; $mp. 104 - 107°.
4 i < f 4 in < f
170,5 g 3-nit!rd-6-(fenyltio)-benzylalkohol suspenderes i 54,5 ml pyridin og 170 ml kloroform og titseties dråpevis ved en temperatur under 20° og i lopet av 30 minutter en opplosning av 78 g tionylklorid i 55 ml kloroform. Det hele rores om i 30 minutter ved 30° og fortynnes derpå med vann. Den organiske fase vakses etter hverandre med vann og vandig natriumbikarbonatopplosning,torkes over magnesiumsulfat og konsentreres. Man får rått 3-nitro-6-(fenyltio)-benzylklorid; smp. 58 - 60°. 170.5 g of 3-nitrid-6-(phenylthio)-benzyl alcohol are suspended in 54.5 ml of pyridine and 170 ml of chloroform and titrated dropwise at a temperature below 20° and over the course of 30 minutes a solution of 78 g of thionyl chloride in 55 ml of chloroform. The whole is stirred for 30 minutes at 30° and then diluted with water. The organic phase is successively washed with water and aqueous sodium bicarbonate solution, dried over magnesium sulphate and concentrated. Crude 3-nitro-6-(phenylthio)-benzyl chloride is obtained; m.p. 58 - 60°.
230 g 3-nitro-6-(fenyltio)-benzylklorid, 540 ml etanol og 320 ml dioksan tilsettes en opplosning av 70,5 g kaliumcyanid i 150 ml vann. Dew hele oppvarmes i 3 timer ved tilbakelopskjoling og konsentreres deretter under redusert trykk. Resten 230 g of 3-nitro-6-(phenylthio)-benzyl chloride, 540 ml of ethanol and 320 ml of dioxane are added to a solution of 70.5 g of potassium cyanide in 150 ml of water. Dew whole is heated for 3 hours by reflux and then concentrated under reduced pressure. The rest
fortynnes med vann og ekstraheres med benzen. Den organiske fase vaskes med vann og dampes inn under redusert trykk. Man får 3-nitro-6-(fenyltio)-fenylacetonitril som brun olje. diluted with water and extracted with benzene. The organic phase is washed with water and evaporated under reduced pressure. 3-nitro-6-(phenylthio)-phenylacetonitrile is obtained as a brown oil.
210,3 g 3-nitro-6-(fenyltio)-fenylacetonitril, 210 ml vann, 210.3 g 3-nitro-6-(phenylthio)-phenylacetonitrile, 210 ml water,
2lo ml konsentrert svovelsyre og 210 ml eddiksyre oppvarmes 20 timer ved tilbakelopskjoling. Man kjoler av og ekstraherer med eter. Den organiske fase vaskes etter hverandre med vann og vandig natriumkarbonatopplosning. Den vandige fase gjores sur med saltsyre og ekstraheres med etylacetat. Den organiske fase vaskes med vann, torkes over magnesiumsulfat, dampes inn under redusert trykk og omkrystalliseres fra ienzen. Man.får 3-nitro-6-(fenyltio)-fenyleddiksyre; smp. 138 -,140°. 210 ml of concentrated sulfuric acid and 210 ml of acetic acid are heated for 20 hours by refluxing. Strip off and extract with ether. The organic phase is washed successively with water and aqueous sodium carbonate solution. The aqueous phase is made acidic with hydrochloric acid and extracted with ethyl acetate. The organic phase is washed with water, dried over magnesium sulfate, evaporated under reduced pressure and recrystallized from the mixture. Man.gets 3-nitro-6-(phenylthio)-phenylacetic acid; m.p. 138 -.140°.
78,4 g 3-nitro-6-(f enyltio)-f enyleddiksyre pg .400 g. polyfos- 78.4 g 3-nitro-6-(phenylthio)-phenylacetic acid pg. 400 g. polyphos-
forsyre holdes under omroring i 90 minutter ved 105 .- 110°, acid is kept under stirring for 90 minutes at 105 .- 110°,
fortynnes detter med is og vann og ekstraheres med benzen. this is diluted with ice and water and extracted with benzene.
Den organiske fase vakses etter hverandre med vann og vandig natriumbikarbonatopplosning, torkes over magnesiumsulfat og dampes inn under redusert trykk. Man får 10,11-dihydro-2-nitro-dibenzo[b,f]tiepin-10-on; smp. 171 - 172°. The organic phase is successively waxed with water and aqueous sodium bicarbonate solution, dried over magnesium sulphate and evaporated under reduced pressure. 10,11-dihydro-2-nitro-dibenzo[b,f]thiepin-10-one is obtained; m.p. 171 - 172°.
165,3 g 10,11-dihydro- 2-nitro-dibenzo [b, f ]tiepin-.lO-on suspen- 165.3 g 10,11-dihydro-2-nitro-dibenzo [b,f]thiepine-.10-one suspension
deres i 6 1 dioksan og tilsettes en opplosning av 63 g natriumborhydrid i 300 ml dioksan og- 300 ml vann. Det hele rores om over natten ved romtemperatur, fortynnes derpå med vann, inn- their in 6 1 dioxane and a solution of 63 g sodium borohydride in 300 ml dioxane and 300 ml water is added. The whole is stirred overnight at room temperature, then diluted with water, in-
stilles noytralt med svovelsyre og ekstraheres med etylacetat. neutralized with sulfuric acid and extracted with ethyl acetate.
Den organiske fase vaskes med vann, torkes over natflumsiiif"at The organic phase is washed with water, dried over night
og dampes inn under redusert trykk. Det oppnådde lo ,"ll-dihydro-2-nitro-dibenzo[b,fjtiepin-lO-ol omkrystalliseres fra etylace- and evaporated under reduced pressure. The obtained 1,1-dihydro-2-nitro-dibenzo[b,fjtiepin-10-ol is recrystallized from ethylace-
tat; smp. 144 - 146° took; m.p. 144 - 146°
124 g 10,11-dihydro-2-nitro-dibenzo[b,fJtiepin-lO-ol suspende- 124 g 10,11-dihydro-2-nitro-dibenzo[b,fJtiepin-10-ol suspension
res i 69,5 ml pyridin, 615 ml benzen og 350 ml kloroform" og tilsettes dråpevis under omroring ved 0° 53 ml tionylklorid. Reaksjonsblandingen rores ytterligere over natten ved romtem- dissolved in 69.5 ml pyridine, 615 ml benzene and 350 ml chloroform" and added dropwise while stirring at 0° 53 ml thionyl chloride. The reaction mixture is further stirred overnight at room temperature
peratur og derpå 30 minutter ved 35 - 40°, avkjoles og for- temperature and then 30 minutes at 35 - 40°, cooled and pre-
tynnes med vann. Den organiske fase vaskes etter hverandre thin with water. The organic phase is washed one after the other
med vann og vandig natriumbikarbonatopplosning, torkes over magnesiumsulfat og dampes inn. Man får 10-klor-lO,11-dihydro-2-nitro-dibenzo[b,fJtiepin; smpi 74 - 77°. with water and aqueous sodium bicarbonate solution, dried over magnesium sulfate and evaporated. One obtains 10-chloro-10,11-dihydro-2-nitro-dibenzo[b,fJthiepine; m.p. 74 - 77°.
Det som utgangsmateriale anvendte 3-[2-(1-piperazinyl)-etylJ-2-oksazolidinon kan fremstilles som folger: 744 g 1-benzylpiperazin tilsettes sammen med 590 g pulverisert kaliumkarbonat, 10 g kaliumjodid og 5 1 toluen 450 g 3-(2-kloretyl)-2-oksazolidinon og oppvarmes i 21 timer ved tilbakelopskjoling. Man kjoler av, filtrerer og konsentrerer under redusert trykk. Man får 3-[2-t4-benzyl-l-piperazinyl)-etylJ-2-oksazolidinon, som koker under et trykk på 2 - 2,5 mm ved 225-235°. Forbindelsen -omkrystalliseres fra etylacetat; smp. 82-84 . Med et overskudd av saltsyre ietanol får man dihydrokloridet; smp. 243-245°. The 3-[2-(1-piperazinyl)-ethyl-2-oxazolidinone used as starting material can be prepared as follows: 744 g of 1-benzylpiperazine are added together with 590 g of powdered potassium carbonate, 10 g of potassium iodide and 5 1 toluene 450 g of 3-( 2-chloroethyl)-2-oxazolidinone and heated for 21 hours at reflux. It is stripped, filtered and concentrated under reduced pressure. 3-[2-t4-benzyl-1-piperazinyl)-ethyl]-2-oxazolidinone is obtained, which boils under a pressure of 2 - 2.5 mm at 225-235°. The compound is recrystallized from ethyl acetate; m.p. 82-84. With an excess of hydrochloric acid and ethanol, the dihydrochloride is obtained; m.p. 243-245°.
291 g 3-[2-(4-benzyl-l-piperazinyl)-etylJ-2-oksazolidinon-di-hydroklorid i 7 1 metanol hydrogeneres i nærvær av 70 g Pd- 291 g of 3-[2-(4-benzyl-1-piperazinyl)-ethyl]-2-oxazolidinone-dihydrochloride in 7 1 of methanol is hydrogenated in the presence of 70 g of Pd-
kull (5 %) ved 50° og 10 ato hydiogen. Reaksjonsblandingen filtreres og konsentreres under redusert trykk. Resten tilset- charcoal (5%) at 50° and 10 ato hydiogen. The reaction mixture is filtered and concentrated under reduced pressure. The rest add-
tes natronlut, ekstraheres med kloroform, filtreres gjennom diatoméjord og konsentreres. Man:får som gul olje 3-[2-(1-pipe-razinyl )-etylJ-2-oksazolidinon. Med et overskudd på saltsyre i metanol-eter får man dihydrokloridetsmp. 203° (spaltning) . sodium hydroxide solution, extracted with chloroform, filtered through diatomaceous earth and concentrated. 3-[2-(1-pipe-razinyl)-ethyl]-2-oxazolidinone is obtained as a yellow oil. With an excess of hydrochloric acid in methanol-ether, dihydrochloride m.p. 203° (decomposition) .
EKSEMPEL 5 EXAMPLE 5
'r 'r
5,9 g 1-(10,11-dihydro-2-jod-dibenzo[b,fJtiepin-10-yl)-pipera- 5.9 g of 1-(10,11-dihydro-2-iodo-dibenzo[b,fJthiepin-10-yl)-pipera-
i in
zin tilsettes sammen med 3,3 g pulverisert kaliumkarbonat, 0,07 zin is added together with 3.3 g of powdered potassium carbonate, 0.07
g kaliumjodid og 40 ml toluen med, 4 ,35 g N-((?-kloretyl)-oksazolidinon og varmes opp i 27 timet ved tilbakelopskjoling. g of potassium iodide and 40 ml of toluene with 4.35 g of N-((?-chloroethyl)-oxazolidinone and heated for 27 hours by refluxing.
Derpå helles på vann og fortynnes i med kloroform. Den organiske fase ekstraheres med 2N saltsyre.;Den vandige fase gjores alkalisk med natronlut og ekstraheres med kloroform. Den organiske fase torkes over magnesiumsulfat og konsentreres under redusert trykk. Resten kromatograferes over aluminiumoksyd. Then pour on water and dilute with chloroform. The organic phase is extracted with 2N hydrochloric acid.; The aqueous phase is made alkaline with caustic soda and extracted with chloroform. The organic phase is dried over magnesium sulfate and concentrated under reduced pressure. The residue is chromatographed over aluminum oxide.
Man får 3- [2- [4- (10,11-dihydro- 2- jjod-dibenzo [b, f Jtiepin- 10-yl) - 1-piperazinylj-etyl]-2-oksazolidinqn, som ved omsetning med maleinsyre-overfores til maleatetj Maleatet smelter ved 176 - 177°. 3-[2-[4-(10,11-dihydro-2-iodo-dibenzo[b,f Jthiepin-10-yl)-1-piperazinyl-ethyl]-2-oxazolidine is obtained, which by reaction with maleic acid transferred to maleatetj The maleate melts at 176 - 177°.
Det som utgangsforbindelse anvendte 1-(10,11-dihydro-2-jod-dibenzoTb,fjtiepin-10-yl)-piperazin kan fremstilles som fol- The starting compound 1-(10,11-dihydro-2-iodo-dibenzoTb,fthiepin-10-yl)-piperazine can be prepared as fol-
ger: gives:
88 g 3-nitro-6-(fenyltio)-fenyleddiksyre i 880 ml etylacetat hydrogeneres ved 40° med hydrogen (10 ato) og 9,5 g 5 %'s palladiumkull. Blandingen filtreres og filtratet konsentreres under redusert trykk. Den erholdte 3-amino-6-(fenyltio)-eddik- 88 g of 3-nitro-6-(phenylthio)-phenylacetic acid in 880 ml of ethyl acetate are hydrogenated at 40° with hydrogen (10 ato) and 9.5 g of 5% palladium charcoal. The mixture is filtered and the filtrate is concentrated under reduced pressure. The obtained 3-amino-6-(phenylthio)-acetic
syre omkrystalliseres fra aceton og smelter ved 160 - 16 2°. acid is recrystallized from acetone and melts at 160 - 16 2°.
50 g 3-amino-6-(f enyltio)-reddiksyre og 500 g polyfosforsyre holdes ved 140° i 10 minutter under omroring. Reaksjonsblan- 50 g of 3-amino-6-(phenylthio)-acetic acid and 500 g of polyphosphoric acid are kept at 140° for 10 minutes with stirring. reaction mixture
dingen innstilles noytral med natronlut og meget vann og eks- the thing is set to neutral with caustic soda and a lot of water and ex-
traheres med kloroform. Den organiske fase vaskes med vann, treated with chloroform. The organic phase is washed with water,
torkes over magnesiumsulfat og dampes inn under redusert trykk. dried over magnesium sulfate and evaporated under reduced pressure.
Det erholdte 2-amino-lO,11-dihydro-dibenzo[b,fjtiepin-10-on omkrystalliseres fra benzen. Smp. 191 - 193°. The 2-amino-10,11-dihydro-dibenzo[b,fthiepin-10-one obtained is recrystallized from benzene. Temp. 191 - 193°.
21,5 g 2-amino-10,11-dihydro-dibenzo[b,fjtiepin-lO-on suspen- 21.5 g of 2-amino-10,11-dihydro-dibenzo[b,fthiepin-10-one suspension
deres ved 5° i 135 ml vann og 54,5 ml konsentrert saltsyre. their at 5° in 135 ml of water and 54.5 ml of concentrated hydrochloric acid.
Til dette tilsetter man dråpevis en opplosning av 9,1 g natrium- To this is added dropwise a solution of 9.1 g of sodium
nitrit i 32 ml vann og rorer i 30 minutter ved 5°. Den erholdte diazoniumsaltopplosning lar man nå tilsette dråpevis ^ed 5° nitrite in 32 ml of water and stir for 30 minutes at 5°. The diazonium salt solution obtained is now allowed to be added dropwise at 5°
og i lopet av 30 minutter til en opplosning av 16,3 g kalium- and in the course of 30 minutes to a solution of 16.3 g of potassium
jodid i 63 ml vann og 5,5 ml konsentrert svovelsyre. Man rorer ytterligere 2 timer ved romtemperatur og deretter ved tilbakelopskjoling inntil slutten av jodsublimeringen. Reaksjonsblan- iodide in 63 ml of water and 5.5 ml of concentrated sulfuric acid. Stirring is continued for a further 2 hours at room temperature and then under reflux until the end of the iodine sublimation. reaction mixture
dingen avkjoles og ekstraheres med etylacetat. Den organiske opplosning vaskes etter hverandre med natriumtiosulfatopplos- the mixture is cooled and extracted with ethyl acetate. The organic solution is washed successively with sodium thiosulphate solution
ning og vann og torkes over magnesiumsulfat. Filtratet dampes inn og kromatograferes på silica-gel. Det erholdte 10,11-dihydro- 2- jod-dibenzo [b , f jtiepin- 10-on omkrystalliseres fra aceton. Smp. 129 - 131°. ning and water and dried over magnesium sulphate. The filtrate is evaporated and chromatographed on silica gel. The obtained 10,11-dihydro-2-iodo-dibenzo [b, f jtiepin-10-one is recrystallized from acetone. Temp. 129 - 131°.
12,0 g 10,11-dihydro- 2- jod-dibenzo |_b, f jtiepin-10-on suspende- 12.0 g 10,11-dihydro-2-iodo-dibenzo |_b, f jtiepin-10-one suspende-
res i 100 ml etanol og tilsettes 6 g natriumborhydrid. Det hele rores over natten, tilsettes derpå vann og ekstraheres med eter. Den organiske fase vaskes med vann inntil noytral dissolve in 100 ml of ethanol and add 6 g of sodium borohydride. The whole is stirred overnight, then water is added and extracted with ether. The organic phase is washed with water until neutral
reaksjon, torkes over magnesiumsulfat og dampes inn. Det erholdte 10,11-dihydro-2-jod-dibenzo[b,fJtiepin-lO-ol omkrystalliseres fra eter. Smp. 131 - 133°. reaction, dried over magnesium sulphate and evaporated. The 10,11-dihydro-2-iodo-dibenzo[b,f]thiepin-10-ol obtained is recrystallized from ether. Temp. 131 - 133°.
En opplosning av 10,3 g 10,11-dihydro-2-jod-dibenzo[b,fJtiepin A solution of 10.3 g of 10,11-dihydro-2-iodo-dibenzo[b,fJtiepine
-lO-ol i 64 ml benzen, 45 ml kloroform og 6,3 ml pyridin tilsettes dråpevis ved -5° 5,7 ml tionylklorid. Det hele rores om 90 minutter ved romtemperatur og 30 minutter ved 35 - 40° og -10-ol in 64 ml of benzene, 45 ml of chloroform and 6.3 ml of pyridine are added dropwise at -5° 5.7 ml of thionyl chloride. The whole thing is stirred for 90 minutes at room temperature and 30 minutes at 35 - 40° and
tilsettes derpå vann. Den organiske fase vaskes etter hverandre med vandig natriumbikarbonatopplosning og vann, torkes over magnesiumsulfat, filtreres og konsentreres. Man får 10-klor-10,11-dihydro-2-jod-dibenzo[b,fJtiepin som brun olje. water is then added. The organic phase is washed successively with aqueous sodium bicarbonate solution and water, dried over magnesium sulfate, filtered and concentrated. 10-chloro-10,11-dihydro-2-iodo-dibenzo[b,fJtiepine is obtained as a brown oil.
10,1 g lO-klor-10,11-dihydro-2-jod-dibenzoj^,fJtiepin og 23,3 10.1 g 10-chloro-10,11-dihydro-2-iodo-dibenzoj^,fJtiepine and 23.3
g piperazin holdes i 1 time ved 120 - 130°!. Reaksjonsblandin--gen avkjoles, fortynnes med 2N natriumhydroksyd og ekstraheres med eter. Den organiske fase vaskes med vann inntil noytral ..xeaksjon og ekstraheres med 500 ml 2N saltsyre. Den vandige fase innstilles alkalisk og ekstraheres med kloroform. Den organiske fase torkes over magnesiumsulfat og konsentreres under redusert trykk. Man får 1-(10,11-dihydro-2-jod-dibenzo[b,fJ tiepin-10-yl)-piperazin som brun olje. g piperazine is kept for 1 hour at 120 - 130°!. The reaction mixture is cooled, diluted with 2N sodium hydroxide and extracted with ether. The organic phase is washed with water until neutral and extracted with 500 ml of 2N hydrochloric acid. The aqueous phase is made alkaline and extracted with chloroform. The organic phase is dried over magnesium sulfate and concentrated under reduced pressure. 1-(10,11-dihydro-2-iodo-dibenzo[b,fJ thiepin-10-yl)-piperazine is obtained as a brown oil.
EKSEMPEL . 6 EXAMPLE . 6
12,5 g 1-(2-brom-IO,11-dihydro-dibenzo[b,fJtiepin-10-yl)-piperazin tilsettes sammen med 13 g pulverisert kaliumkarbonat, 0,2 g kaliumjodid og 1 liter toluen 13,2 g N- ((3-kloretyl) -oksazolidinon og oppvarmes i 25 timer ved tilbakelopskjoling. Derpå helles på isvann og fortynnes med benzen. Benzenopplosningen vaskes noytral med vann og ekstraheres med 2N HC1. Den vandige fase innstilles alkalisk med natrolut og ekstraheres med benzen. Den organiske fase vaskes med vann, torkes over magnesiumsulfat og konsentreres under redusert trykk. Man får rått 3-[2-[4-(2-brom-10,11-dihydro-dibenzo[b,fJtiepin-10-yl)-1-piperazinylJ-etyl]-2-oksazolidinon, som ved omsetning med maleinsyre overfores til maleatet; smp. 170 - 17 2°. 12.5 g of 1-(2-bromo-10,11-dihydro-dibenzo[b,fJtiepin-10-yl)-piperazine are added together with 13 g of powdered potassium carbonate, 0.2 g of potassium iodide and 1 liter of toluene 13.2 g N- ((3-chloroethyl)-oxazolidinone and heated for 25 hours at reflux. Then poured onto ice water and diluted with benzene. The benzene solution is washed neutrally with water and extracted with 2N HCl. The aqueous phase is made alkaline with sodium hydroxide solution and extracted with benzene. The organic phase is washed with water, dried over magnesium sulfate and concentrated under reduced pressure.Crude 3-[2-[4-(2-bromo-10,11-dihydro-dibenzo[b,fJtiepin-10-yl)-1 is obtained -piperazinyl-ethyl]-2-oxazolidinone, which on reaction with maleic acid is converted to the maleate, m.p. 170 - 17 2°.
Det som utgangsmateriale innforte 1-(2-brom-10,11-dihydro-dibenzo j_b, f jtiepin- 10-yl) -piperazin kan fremstilles som folger: En opplosning av 400 g kaliumhydroksyd i 3 1 vann tilsettes ved 45° i en nitrogenatmosfære 179 ml tiofenol og rores om i 15 minutter. Etter tilsetning av 7,1 g kobberpulver og 564 g 5-brom-2-jod-benzosyre oppvarmes det hele 5 timer ved tilbakelopskjoling og filtreres derpå vamt, ansyres under kjoling med 420 ml konsentrert saltsyre og ekstraheres med etylacetat. Den organiske opplosning vaskes med vann, torkes over magnesiumsulfat og dampes inn under redusert trykk. Man får 3-brom-6-(fenyltio)-benzosyre med smp. 171 - 17 3°. The starting material 1-(2-bromo-10,11-dihydro-dibenzo j_b,f jtiepin-10-yl)-piperazine can be prepared as follows: A solution of 400 g of potassium hydroxide in 3 1 of water is added at 45° in a nitrogen atmosphere 179 ml of thiophenol and stir for 15 minutes. After adding 7.1 g of copper powder and 564 g of 5-bromo-2-iodo-benzoic acid, it is heated for a full 5 hours at reflux and then filtered wet, acidified while cooling with 420 ml of concentrated hydrochloric acid and extracted with ethyl acetate. The organic solution is washed with water, dried over magnesium sulfate and evaporated under reduced pressure. This gives 3-bromo-6-(phenylthio)-benzoic acid with m.p. 171 - 17 3°.
478 g 3-brom-6-(fenyltio)-benzosyre i 1,5 1 metanol og 200 ml konsentrert svovelsyre oppvarmes 8 timer ved tilbakelopskjoling. Oppløsningen konsentreres under redusert trykk, tilsettes vann og ekstraheres med eter. Den organiske opplosning vaskes med vandig natriumbikarbonatopplosning, torkes over magnesiumsulfat og konsentreres under redusert trykk. Man får 3-brom-6-(fenyltio)-benzosyre-metylester som en gul olje. 478 g of 3-bromo-6-(phenylthio)-benzoic acid in 1.5 1 of methanol and 200 ml of concentrated sulfuric acid are heated for 8 hours under reflux. The solution is concentrated under reduced pressure, water is added and extracted with ether. The organic solution is washed with aqueous sodium bicarbonate solution, dried over magnesium sulfate and concentrated under reduced pressure. 3-Bromo-6-(phenylthio)-benzoic acid methyl ester is obtained as a yellow oil.
En orarort opplosning av 65 g litiumborhydrid i 1 liter tetrahydrofuran tilsettes dråpevis i en nitrogenatmosfære en opplosning av 483 g 3-brom-6-(fenyltio)-benzosyremetylester i 1 liter tetrahydrofuran i lopet av 120 minutter. Reaksjonsblandingen rores ytterligere om i 4 timer ved tilbakelopskjoling. Oppløs-ningen avkjoles til 5° og tilsettes dråpevis i lopet av 3 timer 700 ml 3N saltsyre. Etter tilsetning av ca. 5 1 vann ekstraheres blandingen med eter. Den organiske opplosning vaskes med vann og torkes over magnesiumsulfat. Man får rå 3-brom-6-(fe-nyltio)-benzylalkohol som en gul olje. An undiluted solution of 65 g of lithium borohydride in 1 liter of tetrahydrofuran is added dropwise in a nitrogen atmosphere to a solution of 483 g of 3-bromo-6-(phenylthio)-benzoic acid methyl ester in 1 liter of tetrahydrofuran over the course of 120 minutes. The reaction mixture is further stirred for 4 hours at reflux. The solution is cooled to 5° and 700 ml of 3N hydrochloric acid is added dropwise over the course of 3 hours. After adding approx. 5 1 water, the mixture is extracted with ether. The organic solution is washed with water and dried over magnesium sulfate. Crude 3-bromo-6-(phenylthio)-benzyl alcohol is obtained as a yellow oil.
445 g 3-brom-6-(fenyltio)-benzylalkohol opploses i 800 ml benzen og oppvarmes ved tilbakelopskjoling. 165 ml tionylklorid tilfores dråpevis og det hele kokes ytterligere 90 minutter. Etter avdampningen av opplosniirgsmidlet får man 3-brom-6- (fe-nyltio)-benzylklorid som en brun olje. 445 g of 3-bromo-6-(phenylthio)-benzyl alcohol are dissolved in 800 ml of benzene and heated at reflux. 165 ml of thionyl chloride are added dropwise and the whole is boiled for a further 90 minutes. After evaporation of the solvent, 3-bromo-6-(phenylthio)-benzyl chloride is obtained as a brown oil.
136.5 g kaliumcyanid i 183 ml vann oppvarmes i lo timer ved tilbakelopskjoling og i en nitrogenatmosfære med 470 g 3-brom-6-(fenyltio)-benzylklorid i 470 ml etanol. Etanolen destilleres av under redusert trykk, resten fortynnes med vann og ekstraheres med eter. Ekstraktene vaskes med vann, torkes over magnesiumsulfat og dampes inn. Man får 3-brom-6-(fenyltio)-fenylacetonitril som en brun olje. 136.5 g of potassium cyanide in 183 ml of water are heated for 10 hours under reflux and in a nitrogen atmosphere with 470 g of 3-bromo-6-(phenylthio)-benzyl chloride in 470 ml of ethanol. The ethanol is distilled off under reduced pressure, the residue is diluted with water and extracted with ether. The extracts are washed with water, dried over magnesium sulphate and evaporated. 3-Bromo-6-(phenylthio)-phenylacetonitrile is obtained as a brown oil.
442.6 g 3-brom-6-(fenyltio)-fenylacetonitril, 775 ml etanol, 442.6 g 3-bromo-6-(phenylthio)-phenylacetonitrile, 775 ml ethanol,
37 2 g kaliumhydroksyd og 290 ml vann oppvarmes i 8 timer ved 37 2 g of potassium hydroxide and 290 ml of water are heated for 8 hours at
tilbakelopskjoling. Etanolen dampes av under redusert trykk. Resten tilsettes vann inntil fullstendig opplosning og de noytrale deler trekkes ut med toluen. Den vandige opplosning avkjoles, ansyres med konsentrert saltsyre og ekstraheres med etylacetat. Den organiske fase torkes over magnesiumsulfat med vann og konsentreres under redusert trykk. Den erholdte rå <* >3-brom-6-(fenyltio)-fenyleddiksyre omkrystalliseres fra benzen-heksan; smp. 118 - 120°. throwback dress. The ethanol is evaporated under reduced pressure. Water is added to the residue until complete dissolution and the neutral parts are extracted with toluene. The aqueous solution is cooled, acidified with concentrated hydrochloric acid and extracted with ethyl acetate. The organic phase is dried over magnesium sulfate with water and concentrated under reduced pressure. The crude 3-bromo-6-(phenylthio)-phenylacetic acid obtained is recrystallized from benzene-hexane; m.p. 118 - 120°.
J -f '■ o J -f '■ o
2300 g polyfosforsyre oppvarmes til ]?28 i en nitrogenatmosfære, 2300 g of polyphosphoric acid are heated to ]?28 in a nitrogen atmosphere,
* ss * pp
tilsettes hurtig 302 g 3-brom-6-(fenyltio)-fenyleddiksyre og rores om 8 minutter ved 120 - 130°. Etter tilsetning av 1,5 kg små isbiter ekstraheres det hele med benzen. Den organiske opplosning vaskes etter hverandre med vann og vandig^ natriumbikarbo-natopplbsning og torkes over magnesiumsulfat. Det erholdte 2-brom-10,11-dihydro-dibenzo[b,fJtiepin-10-on destilleres under redusert trykk; kokepunkt (0,05 mm) 170 - 175°. Forbindelsen omkrystalliseres fra aceton-heksan; smp. 143 - 145°. quickly add 302 g of 3-bromo-6-(phenylthio)-phenylacetic acid and stir for 8 minutes at 120 - 130°. After adding 1.5 kg of small ice cubes, the whole is extracted with benzene. The organic solution is washed successively with water and aqueous sodium bicarbonate solution and dried over magnesium sulfate. The 2-bromo-10,11-dihydro-dibenzo[b,fJtiepin-10-one obtained is distilled under reduced pressure; boiling point (0.05 mm) 170 - 175°. The compound is recrystallized from acetone-hexane; m.p. 143 - 145°.
50 g 2-brom-10,11-dihydro-dibenzo[b,fJtiepin-10-on dispergeres 50 g of 2-bromo-10,11-dihydro-dibenzo[b,fJtiepin-10-one are dispersed
i 250 ml etanol, tilsettes 9,9 g natriumborhydrid og rores om in 250 ml of ethanol, add 9.9 g of sodium borohydride and stir
1 time. Etter tilsetning av vann ekstraheres det hele med eter. 1 hour. After adding water, the whole is extracted with ether.
Den organiske fase vaskes med vann, torkes over magnesiumsulfat og dampes inn. Man får 2-brom-10,11-dihydro-dibenzo[b,fJ tiepin-10-ol; smp. 108 - 110°. The organic phase is washed with water, dried over magnesium sulphate and evaporated. 2-Bromo-10,11-dihydro-dibenzo[b,f] thiepin-10-ol is obtained; m.p. 108 - 110°.
49,9 g 2-brom-10,11-dihydro-dibenzo[b,fJtiepin-lO-ol, 250-ml benzen og 18 g fint pulverisert kalsiumHorid mettes ved 15° 49.9 g of 2-bromo-10,11-dihydro-dibenzo[b,fJtiepin-10-ol, 250 ml of benzene and 18 g of finely powdered calcium chloride are saturated at 15°
med saltsyregass og rores derpå videre 3 timer ved romtempera- with hydrochloric acid gas and then stirred for a further 3 hours at room temperature
tur. Fellingen filtreres fra og vaskes med benzen. Filtratet konsentreres under redusert trykk. Man får 2-brom-10-klor-10,11-dihydro-dibenzo[b,fJtiepin; smp. 122,5 - 124°. trip. The precipitate is filtered off and washed with benzene. The filtrate is concentrated under reduced pressure. One obtains 2-bromo-10-chloro-10,11-dihydro-dibenzo[b,fJthiepine; m.p. 122.5 - 124°.
32,5 g 2-brom-10-klor-10,11-dihydro-dibenzo[b,fjtiepin i 120 32.5 g of 2-bromo-10-chloro-10,11-dihydro-dibenzo[b,fjthiepine in 120
ml kloroform oppvarmes sammen med 63,3 g 1-karbetoksypiperazin i 24 timer ved tilbakelopskjoling. Derpå helles på isvann og fortynnes med kloroform. Den organiske fase torkes over magnesiumsulfat og konsentreres under redusert trykk. Man får gult, ml of chloroform is heated together with 63.3 g of 1-carbethoxypiperazine for 24 hours at reflux. It is then poured onto ice water and diluted with chloroform. The organic phase is dried over magnesium sulfate and concentrated under reduced pressure. You get yellow,
rått 1-karbetoksy-4- ( 2-brom-10,11-dihydro-dibenzo [b, f.jtiepin-10-yl)-piperazin. Hydrokloridet fremstilles ved- omsetning., avri.r basen med etanolisk saltsyre; smp. 195°.. ~,s- ,^ r— ,j«/t crude 1-Carbethoxy-4-(2-bromo-10,11-dihydro-dibenzo[b,f]thiepin-10-yl)-piperazine. The hydrochloride is prepared by reacting the base with ethanolic hydrochloric acid; m.p. 195°.. ~,s- ,^ r— ,j«/h
' 7B< lZi~' 0 :i& itj. b3 . -CflJt.fi ' 7B< lZi~' 0 :i& itj. b3. -CflJt.fi
47,2 g 1-karbetoksy- 4- ( 2-brom-10 ,11- dihyjdr.or;dijD^ 10-yl)-piperazin-hydroklorid, 585 ml etylenglykol, 32,8 g ka-li limhydroksyd og 1,95 ml vann oppvarmes ( :iu~^ JjCm^ T^^^ r.,. plX f1^ 0°. 47.2 g of 1-carbethoxy-4-(2-bromo-10,11-dihydr.or;dijD^10-yl)-piperazine hydrochloride, 585 ml of ethylene glycol, 32.8 g of potassium hydroxide and 1.95 ml of water is heated ( :iu~^ JjCm^ T^^^ r.,. plX f1^ 0°.
Deretter helles på vann og ekstraheres rn\e# y& P^ fprjM i^ P$ fy~ Q£f3p- Then pour on water and extract rn\e# y& P^ fprjM i^ P$ fy~ Q£f3p-
ni ske opplosning ekstraheres med 2N %%l%s^Y/r^-.tj§-al,t;SYre^<pp>-4b;sjilnine spoonfuls of solution are extracted with 2N %%l%s^Y/r^-.tj§-al,t;SYre^<pp>-4b;sjil
ningen innstilles alkalisk, ekstraheres i~med .kloroform,, vaskes The mixture is made alkaline, extracted with chloroform, washed
med vann, torkes over magnesiumsulfat ;qg- k^nggntr^e^^s ^unde^ with water, dried over magnesium sulphate ;qg- k^nggntr^e^^s ^unde^
redusert trykk. Man får krystallinsk iU (^^rom^lO^Ll^^^dr^ reduced pressure. One obtains crystalline iU (^^rom^lO^Ll^^^dr^
dibenzo j b, f j tiepin-10-yl)-piperazin; smp.-11 2rZ- 115 f ^ dibenzo j b, f j thiepin-10-yl)-piperazine; mp.-11 2rZ- 115 f ^
. ii. rxre-i s r-an^cf — {ol J X vas 'i) . ii. rxre-i s r-an^cf — {ol J X vas 'i)
EKSEMPEL 7 EXAMPLE 7
9,4 g 10-klor-2-f luor-10,11-dihydro-dibenzo [b, f Jtiepirr; 60^ml kloroform og 17,1 g 3-[2-(1-piperazinyl)-etylJ-2-oksazoiidinon oppvarmes 12 timer under tilbakelopsbetingelser, helles der- 9.4 g of 10-chloro-2-fluoro-10,11-dihydro-dibenzo [b, f Jtiepirr; 60 ml of chloroform and 17.1 g of 3-[2-(1-piperazinyl)-ethyl J-2-oxazoiidinone are heated for 12 hours under reflux conditions, poured there-
etter på isvann og ekstraheres med kloiroform-eter. Den organiske fase ekstraheres med 2N saltsyre. Den vandige fase gjores alkalisk med natronlut og ekstraheres med benzen. Den organiske fase vaskes med vann og dampes inn. Man får rått 3-[2-[4- (2-f luor-10,11-dihydro-dibenzo[b, f jtiepin-10-yl) -1?-piperazinylJ-etyl]-2-oksazolidinon, som etter omkrystallisa- after on ice water and extracted with chloroform-ether. The organic phase is extracted with 2N hydrochloric acid. The aqueous phase is made alkaline with caustic soda and extracted with benzene. The organic phase is washed with water and evaporated. One obtains crude 3-[2-[4-(2-fluoro-10,11-dihydro-dibenzo[b,f jthiepin-10-yl)-1?-piperazinyl]-ethyl]-2-oxazolidinone, which after recrystallization -
sjon fra etylacetat smelter ved 158-159°. Denne base omsettes med maleinsyre; det på denne måte oppnådde maleat smelter ved 199-200°. tion from ethyl acetate melts at 158-159°. This base is reacted with maleic acid; the maleate thus obtained melts at 199-200°.
Det som utgangsarateriale anvendte 10-klor-2-fluor-10,11-dihydro-dibenzo [b,f]tiepin kan fremstilles som folger: 160 g 5-fluor-antranilsyre-hydroklorid suspenderes i 768 ml vann og 76,8 ml konsentrert saltsyre ved 0-5°. Den oppnådde suspensjon tilsettes under omroring ved 0-5° i lopet av 30 min. The 10-chloro-2-fluoro-10,11-dihydro-dibenzo [b,f]thiepine used as starting material can be prepared as follows: 160 g of 5-fluoro-anthranilic acid hydrochloride are suspended in 768 ml of water and 76.8 ml of concentrated hydrochloric acid at 0-5°. The obtained suspension is added with stirring at 0-5° over the course of 30 min.
en opplosning av 61,5 g natriumnitril i 153,5 ml vann. Den oppnådde diazoniumsaltopplbsning rores videre om i 15 minutter og tilsettes deretter ved 0-2° en opplosning av 193,5 g kaliumjodid i 41,5 nil konsentrert svovelsyre og 4oo ml vann dråpevis. Reaksjonsblandingen rores om i 3 timer under tilbakelbpsbetingelser, kjoles derpå av og ekstraheres med etylacetat. a solution of 61.5 g of sodium nitrile in 153.5 ml of water. The obtained diazonium salt solution is stirred further for 15 minutes and then a solution of 193.5 g of potassium iodide in 41.5 nil of concentrated sulfuric acid and 400 ml of water is added dropwise at 0-2°. The reaction mixture is stirred for 3 hours under reflux conditions, then cooled and extracted with ethyl acetate.
Den organiske fase vaskes med vandig natriumtiosulfatopplbs-ning-, torkes over-natriumsulfat og dampes inn. Man får 5-fluor-2-jod-benzoesyre som smelter ved 142-145°. The organic phase is washed with aqueous sodium thiosulfate solution, dried over sodium sulfate and evaporated. 5-fluoro-2-iodo-benzoic acid is obtained which melts at 142-145°.
I en nitrogenatmosfære tilsettes en opplosning pa 150 g kaliumhydroksyd i 850 ml vann ved 55° 47,5 ml tiofenol. Blandingen rores om i 15 minutter pg tilsettes derpå 1,9 g kobberpulver og 207 g 5-fluar—2-jod-benzoesyre. Reaksjonsblandingen oppvarmes 7 tiraer-under^ilbakelbpsbetingelser, filtreres varm, avkjbjjsE og ansyres med konsentrert saltsyre. Det utfallende produkt filtreres av, vaskés med vann og torkes. Man får 3-fluor-6-(fenyltio)-benzosyre sam smelter ved 146-148°. «?In a nitrogen atmosphere, a solution of 150 g of potassium hydroxide in 850 ml of water at 55° is added to 47.5 ml of thiophenol. The mixture is stirred for 15 minutes and then 1.9 g of copper powder and 207 g of 5-fluoro-2-iodo-benzoic acid are added. The reaction mixture is heated for 7 hours under baking conditions, filtered while hot, evaporated and acidified with concentrated hydrochloric acid. The precipitated product is filtered off, washed with water and dried. 3-Fluoro-6-(phenylthio)-benzoic acid is obtained and melts at 146-148°. "?
144 g 3-fluor-6-(fenyltio)-benzosyre i 1000 ml tetrahydrofuran tilsettes dråpevis i en nitrogenatmosfære under tilbakelbpsbetingelser en 70%'ig natrium-dihydro-bis-(2-metoksyetoksy)-aluminatopplbsning i benzen. Reaksjonsblandingen holdes ytterligere 2 timer under tilbakelbpsbetingelser. Etter tilsetning av 400 ml benzen kjoles det hele av til 20°, ansyres 144 g of 3-fluoro-6-(phenylthio)-benzoic acid in 1000 ml of tetrahydrofuran are added dropwise in a nitrogen atmosphere under reflux conditions to a 70% sodium dihydro-bis-(2-methoxyethoxy)-aluminate solution in benzene. The reaction mixture is kept for a further 2 hours under reflux conditions. After adding 400 ml of benzene, the whole is cooled to 20°, acidified
med 435 ml 3N saltsyre og tilsettes deretter 600 ml konsentrert saltsyre. Den organiske fase vaskes med vann, torkes over natriumsulfat og dampes inn. Man får 3-fluor-6-(fenyltio)-benzylalkohol som en tykk olje. with 435 ml of 3N hydrochloric acid and then add 600 ml of concentrated hydrochloric acid. The organic phase is washed with water, dried over sodium sulphate and evaporated. 3-Fluoro-6-(phenylthio)-benzyl alcohol is obtained as a thick oil.
129 g 3-fluor-6-(fenyltio)-benzylalkohol opplbses i 385 ml 129 g of 3-fluoro-6-(phenylthio)-benzyl alcohol are dissolved in 385 ml
benzen og oppvarmes under tilbakelbpsbetingelser. 73 ml tionyl- benzene and heated under reflux conditions. 73 ml of thionyl
klorid tilsettes og det kokes videre 30 minutter. Reaksjonsblandingen dampes inn under redusert trykk. Man får 3-fluor-6-(fenyltio)-benzylklorid som rodbrun olje. chloride is added and it is boiled for a further 30 minutes. The reaction mixture is evaporated under reduced pressure. 3-Fluoro-6-(phenylthio)-benzyl chloride is obtained as a red-brown oil.
18,6 g natriumcyanid i 222 ml dimetylsulfoksyd tilsettes på 18.6 g of sodium cyanide in 222 ml of dimethylsulfoxide are added
en gang ved 50° 74 g 3-fluor-6-(fenyltio)-benzylklorid i 75 ml dimetylsulfoksyd. Den oppnådde morke reaksjonsopplosning rores om 1 time ved 45-50°, helles derpå på 1500 ml isvann og ekstraheres med eter. Den organiske fase vaskes tre ganger hver gang med 500 ml vann, torkes over natriumsulfat og dampes inn. Man får 3-fluor-6-(fenyltio)-fenylacetonitril som en rodlig olje. 80 g 3-fluor-6-(fenyltio)-fenylacetonitril, '225 ml etanol, 75,5 g kaliumhydroksyd og 225 ml vann oppvarmes 9r?etimer-^under tilbakelopsbetingelser. Derpå dampes etÆriolen iaveuHt*er^t-i£'--C bakelopsbetingelser og resten tilsettes 'Vann inntil-fullstendig opplosning, hvoretter de noytrale délSr-^treKkes^iife-med^benzen. Den vandige opplosning ansyres med konsentrert<;>■såltayrere^.r.fv ekstraheres med kloroform. Den organ4<:>ske<p>£åsé"Vaskesf'med'TV«nn, torkes over natriumsulf at og dampes inn'1 under redusert • trykk. Man får 3-f luor-6-(f enyltio)-f enyleddiksy?re .som smekter ved^ 80-83°. once at 50° 74 g of 3-fluoro-6-(phenylthio)-benzyl chloride in 75 ml of dimethyl sulfoxide. The obtained dark reaction solution is stirred for 1 hour at 45-50°, then poured into 1500 ml of ice water and extracted with ether. The organic phase is washed three times each time with 500 ml of water, dried over sodium sulphate and evaporated. 3-Fluoro-6-(phenylthio)-phenylacetonitrile is obtained as a reddish oil. 80 g of 3-fluoro-6-(phenylthio)-phenylacetonitrile, 225 ml of ethanol, 75.5 g of potassium hydroxide and 225 ml of water are heated for 9 hours under reflux conditions. The solvent is then evaporated under reflux conditions and the residue is added to water until complete dissolution, after which the neutral solvents are treated with benzene. The aqueous solution is acidified with concentrated <;>■såltayrere^.r.fv extracted with chloroform. The organic matter is washed with TV, dried over sodium sulfate and evaporated under reduced pressure. 3-fluoro-6-(phenylthio)-phenylenedioxy is obtained ?re .which wilts at^ 80-83°.
900 g polyf osf orsyre oppvarmes i en nitrogenatmosfære-; tj.1 128°, tilsettes raskt 80 g 3-fluor-6-(fenyltio)-fenyleddiksyre og rores om 10 minutter ved 120-130 (indre temperatur) ... Eti;er" tilsetning av is-splinter ekstraheres det hele med benzen. 900 g of polyphosphoric acid are heated in a nitrogen atmosphere; i.e. 128°, 80 g of 3-fluoro-6-(phenylthio)-phenylacetic acid are quickly added and stirred for 10 minutes at 120-130 (internal temperature) ... After adding ice chips, the whole is extracted with benzene.
Den organiske fase vaskes etter hverandre med vann, vandig natriumkarbonatopplosning og vaskes igjen med vann, torkes over natriumsulfat og dampes inn. Man oppnår 2-fluor-10,11-dihydro-dibenzo [b, f Jtiepin-10-on som koker ved 118° (0,07 mm); Smp. 98-100°. The organic phase is washed successively with water, aqueous sodium carbonate solution and washed again with water, dried over sodium sulphate and evaporated. One obtains 2-fluoro-10,11-dihydro-dibenzo [b, f Jtiepin-10-one boiling at 118° (0.07 mm); Temp. 98-100°.
22 g 2-fluor-lO,11-dihydro-dibenzo[b,fJtiepin-10-on suspenderes i 110 ml etanol og tilsettes 6,1 g natriumborhydrid. Reaksjonsblandingen oppvarmes 10-15 minutter under tilbakelopsbetingelser tilsettes derpå vann og ekstraheres med kloroform. Den organiske fase vaskes_med vann torkes over natriumsulfat og dampes inn. Man får 2-fluor-10,11-dihydro-dibenzo[b,f]tiepin-lO-ol som smelter ved 110-113°.. 22 g of 2-fluoro-10,11-dihydro-dibenzo[b,f]thiepin-10-one are suspended in 110 ml of ethanol and 6.1 g of sodium borohydride are added. The reaction mixture is heated for 10-15 minutes under reflux conditions, water is then added and extracted with chloroform. The organic phase is washed with water, dried over sodium sulphate and evaporated. You get 2-fluoro-10,11-dihydro-dibenzo[b,f]thiepin-10-ol, which melts at 110-113°.
21,2 g 2-fluor-10,11-dihydro-dibenzo[b,f]tiepin-10-ol, 110 ml benzen og 7,9 g fint pulverisert kalsiumklorid mettes ved 15° med saltsyregass (2 timer). Fellingen filtreres av og vaskes med benzen. Filtratet dampes inn under redusert trykk. Man får lO-klor-2-fluor-10,11-dihydro-dibenzo[b,fjtiepin som rosa-fargede krystaller som smelter ved 90-92°. 21.2 g of 2-fluoro-10,11-dihydro-dibenzo[b,f]thiepin-10-ol, 110 ml of benzene and 7.9 g of finely powdered calcium chloride are saturated at 15° with hydrochloric acid gas (2 hours). The precipitate is filtered off and washed with benzene. The filtrate is evaporated under reduced pressure. 10-chloro-2-fluoro-10,11-dihydro-dibenzo[b,fjthiepine is obtained as pink-coloured crystals melting at 90-92°.
EKSEMPEL 8 EXAMPLE 8
24,1 g 3-[2-[4-(10,ll-dihydro-2-nitro-dibenzo[b,fJtiepin-lO-yl)-1-piperazinylj-etyl]-2-oksazolidinon i 2000 ml etylacetat hydrogeneres i nærvær av 5,7 g 5%'ig palladiumkull ved 70° og 10 ato .hydrogen. Etter filtrering dampes filtratet inn under redusert trykk. Man får 3-[2-[4-(2-araino-10,11-dihydro-i dibenzo [b, f jtiepin-10-yo l) -l-piperaziny*li]-etyl]-2-oksazolidinon som smelter ved 193-196 . Etter kroma^bograf isk rensing over aluminiumoksyd med aceton-heksan som-elueringsmiddel får man et rent produkt som smelter ved 195,5-196,5°. 24.1 g of 3-[2-[4-(10,11-dihydro-2-nitro-dibenzo[b,fJthiepin-10-yl)-1-piperazinyl-ethyl]-2-oxazolidinone in 2000 ml of ethyl acetate are hydrogenated in presence of 5.7 g of 5% palladium charcoal at 70° and 10 at of hydrogen. After filtration, the filtrate is evaporated under reduced pressure. One obtains 3-[2-[4-(2-araino-10,11-dihydro-1 dibenzo[b,f]thiopin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone which melts at 193-196. After chromatographic purification over aluminum oxide with acetone-hexane as eluent, a pure product is obtained which melts at 195.5-196.5°.
EKSEMPEL 9 EXAMPLE 9
7 g 3-[4- (2-amino-10,11-dihydro-dibenzo[b, ftjtiepin- 10-yl)-1-piperazinyl]-etyl]-2-oksazolidinon, 13,1 nil£40%,ig formaldehyd og 61 ml acetonitril tilsettes 3,32 g natriunbyanborhydrid og tilsettes dråpevis i lopet av 10 minutter IL,5 ml eddiksyre. Det hele rores videre om i 90 minutter, tilsettes videre dråpevis 1,5 ml eddiksyre og rores videre i 15 minutter. Det hele ekstraheres nå med 200 ml eter og den organiske fase vaskes tre ganger med IN. vandig kaliumhydroksydopplbsning, torkes over natriumsulfat og dampes inn. Man får 3-[2-[4-(10,ll-dihydro-2-dimetylamino-dibenzo[b,f Jtiepin-10-yl)-l-piperazinyl]-etyl]-2-oksazolidinon som smelter ved 168-170<*>. Etter omkrystallisasjon av forbindelsen fra etanol smelter den ved 171-173°. Ved omsetning med maleinsyre får man det tilsvarende maleat som etter omkrystallisasjon fra acetonitril smelter ved 143,5-144,5°. 7 g of 3-[4-(2-amino-10,11-dihydro-dibenzo[b,ftythiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone, 13.1 nil£40%,ig formaldehyde and 61 ml of acetonitrile, 3.32 g of sodium borohydride are added and 1.5 ml of acetic acid is added dropwise over 10 minutes. The whole thing is stirred again for 90 minutes, then 1.5 ml of acetic acid is added dropwise and stirred for 15 minutes. The whole is now extracted with 200 ml of ether and the organic phase is washed three times with IN. aqueous potassium hydroxide solution, dried over sodium sulphate and evaporated. 3-[2-[4-(10,11-dihydro-2-dimethylamino-dibenzo[b,f Jthiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone is obtained which melts at 168-170 <*>. After recrystallization of the compound from ethanol, it melts at 171-173°. When reacted with maleic acid, the corresponding maleate is obtained which, after recrystallization from acetonitrile, melts at 143.5-144.5°.
EKSEMPEL 10 EXAMPLE 10
8,3 g 1-(2-klor-10,11-dihydro-dibenzo[b,fJtiepin-10-yl)-piperazin tilsettes sammen med 11,6 g pulverisert kaliumkarbonat, 0,2 g kaliumjodid og 80 ml toluen med 8,6 g p-kloretyl-3-metyl-2-imidazolidinon og oppvarmes 20 timer under tilbakel6psbetingelser0 Reaksjonsblandingen helles på vann, 8.3 g of 1-(2-chloro-10,11-dihydro-dibenzo[b,fJtiepin-10-yl)-piperazine are added together with 11.6 g of powdered potassium carbonate, 0.2 g of potassium iodide and 80 ml of toluene with 8 .6 g of p-chloroethyl-3-methyl-2-imidazolidinone and heated for 20 hours under reflux conditions. The reaction mixture is poured onto water,
den organiske fase vaskes med vann, torkes over natriumsulfat og dampes inn. Man oppnår 1-[2-[4-(-klor-10,11-dihydro-dibenzo [b,fJtiepin-10-yl)-1-piperazinylJ-etyl]-3-metyl-2-imidazolidinon som brun olje. Ved omsetning av denne forbindelse med maleinsyre i etanol-eter oppnår man det tilsvarende maleat som smelter ved 186-188°. the organic phase is washed with water, dried over sodium sulphate and evaporated. One obtains 1-[2-[4-(-chloro-10,11-dihydro-dibenzo [b,fJthiepin-10-yl)-1-piperazinyl]-ethyl]-3-methyl-2-imidazolidinone as a brown oil. By reacting this compound with maleic acid in ethanol-ether, the corresponding maleate is obtained which melts at 186-188°.
EKSEMPEL 11 EXAMPLE 11
11,9 g lO-klor-IO,ll-dihydro-2-(dimetylsulfamoyl)-dibenzo[b,f]-tiepin i 250 ml kloroform tilsettes 20 g 3-[2-(1-pipera-zinyl) -etyl J-2-oksazolidinon og oppvarmes 2 4 timer under tilbake- . lopsbetingelser. Reaksjonsblandingen dampes inn under redusert trykk og resten tas opp i etylacetat. Den organiske fase vaskes med vann, torkes over magnesiumsulfat og dampes inn under redusert trykk. Resten opploses i benzen og filtreres gjennom en med lOO g aluminiumoksyd (aktivitetstrinn II) fyllt soyle. Eluatet dampes inn og kromatograferes for ytterligere rensning på 75 g silicagel (0,2-0,5 mm), hvorved en blanding i forholdet 1:1 av kloroform mettet med konsentrert ammoniakk: karbontetraklorid anvendes som elueringsmiddel. Det rensede produkt omkrystalliseres fra etylacetat-petroleter. Man får 3-[2-[4-{lo,ll-dihydro-2-(dimetylsulfamoyl)-dibenzo[b, f Jtiepin-10-yl}-1-piperazinylJ-etyl]-2-oksazolidinon som smelter ved 164-165°. 11.9 g of 10-chloro-10,11-dihydro-2-(dimethylsulfamoyl)-dibenzo[b,f]-thiepine in 250 ml of chloroform is added to 20 g of 3-[2-(1-piperazinyl)-ethyl J -2-oxazolidinone and heated for 2 4 hours under reflux. race conditions. The reaction mixture is evaporated under reduced pressure and the residue is taken up in ethyl acetate. The organic phase is washed with water, dried over magnesium sulphate and evaporated under reduced pressure. The residue is dissolved in benzene and filtered through a sieve filled with 100 g of aluminum oxide (activity level II). The eluate is evaporated and chromatographed for further purification on 75 g of silica gel (0.2-0.5 mm), whereby a 1:1 mixture of chloroform saturated with concentrated ammonia: carbon tetrachloride is used as eluent. The purified product is recrystallized from ethyl acetate-petroleum ether. One obtains 3-[2-[4-{lo,ll-dihydro-2-(dimethylsulfamoyl)-dibenzo[b,f Jthiepin-10-yl}-1-piperazinyl J-ethyl]-2-oxazolidinone which melts at 164- 165°.
Det som utgangsmateriale anvendte 10-klor-lO,ll-dihydro-2-(dimetylsulfamoyl)-dibenzo[b,fJtiepin kan fremstilles som The 10-chloro-10,11-dihydro-2-(dimethylsulfamoyl)-dibenzo[b,fJthiepine used as starting material can be prepared as
folger: following:
22,9 g 2-amino-10,11-dihydro-dibenzo[b,fJtiepin-10-on suspenderes i 50 ml konsentrert saltsyre og tilsettes ved 0° i lopet av 30 minutter 8,6 g natriumnitrit i 20 ml vann dråpevis. Den oppnådde suspensjon rores om i 3-4 timer ved 0°. De fremde-les uopplbste deler fjernes ved filtrering og det kalde filtrat tilsettes straks i en til 10-20° kjolt opplosning av 73 g svoveldioksyd i 150 ml iseddik som inneholder 7,6 g kupriklorid og 50 ml benzen. Den oppnådde blanding oppvarmes 5-10 minutter til 40-45° og rores deretter om i 3 timer ved 20°. Det hele helles på isvann og ekstraheres med benzen. Den organiske fase vaskes med vann, torkes over magnesiumsulfat, filtreres og dampes inn. Resten loses opp i dioksan, tilsettes 50 mg dimetylamin og las henstå i 15 timer ved romtemperatur. Reaksjonsblandingen dampes inn under redusert trykk, resten loses opp i benzen for rensning og kromatograferes på silica-gel (partikkelstbrrelse 0,2-0,5 mm) med kloroform som elueringsmiddel. Man oppnår 10,ll-dihydro-2-(dimetylsulfamoyl)-dibenzo-[b,fjtiepin-10-on, hvis IR-spektrum står i overensstemmelse med strukturen. 22.9 g of 2-amino-10,11-dihydro-dibenzo[b,fJtiepin-10-one are suspended in 50 ml of concentrated hydrochloric acid and 8.6 g of sodium nitrite in 20 ml of water are added dropwise at 0° over the course of 30 minutes. The resulting suspension is stirred for 3-4 hours at 0°. The still undissolved parts are removed by filtration and the cold filtrate is immediately added to a cooled to 10-20° solution of 73 g of sulfur dioxide in 150 ml of glacial acetic acid containing 7.6 g of cupric chloride and 50 ml of benzene. The resulting mixture is heated for 5-10 minutes to 40-45° and then stirred for 3 hours at 20°. The whole is poured into ice water and extracted with benzene. The organic phase is washed with water, dried over magnesium sulphate, filtered and evaporated. The residue is dissolved in dioxane, 50 mg of dimethylamine is added and left to stand for 15 hours at room temperature. The reaction mixture is evaporated under reduced pressure, the residue is dissolved in benzene for purification and chromatographed on silica gel (particle size 0.2-0.5 mm) with chloroform as eluent. One obtains 10,11-dihydro-2-(dimethylsulfamoyl)-dibenzo-[b,fthiepin-10-one, whose IR spectrum is in agreement with the structure.
jf cf
14 g 10, ll-dihydro-2-(dimetylsulfamoyl)-dibenzo[b,f Jtiepin-10-on i 200 ml dioksan tilsettes 3,5 g natriumborhydrid i 15 ml vann t>g rores om i 4 timer ved 40°. Reaksj onsblandingen dampes inn under redusert trykk og resten loses opp i etylacetat og vann. .Den organiske fase vaskes med vann, torkes og dampes inn. Man oppnår 10,ll-dihydro-2-(dimetylsulfamoy l)-dibenzo[b,f Jtiepin-ao-oi. 14 g of 10,11-dihydro-2-(dimethylsulfamoyl)-dibenzo[b,f Jtiepin-10-one in 200 ml of dioxane is added to 3.5 g of sodium borohydride in 15 ml of water and the mixture is stirred for 4 hours at 40°. The reaction mixture is evaporated under reduced pressure and the residue is dissolved in ethyl acetate and water. .The organic phase is washed with water, dried and evaporated. One obtains 10,11-dihydro-2-(dimethylsulfamoyl)-dibenzo[b,f Jtiepin-ao-oi.
I en blanding på 12 g 10,ll-dihydro-2-(dimetyl-sulfamoyl)-dibenzo[b,fJtiepin-lO-ol, 250 ml benzen og 20 g kalsiumklorid innfores ved 10° i lopet av 2 timer saltsyregass. Deretter las reaksj onsblandingen henstå 20 timer ved romtemperatur. Ved innfbring av nitrogen drives den overskytende saltsyre ut. Det hele filtreres av og dampes inn under redusert trykk. Man får 10-klor-10,ll-dihydro-2-(dimetylsulfamoyl)-dibenzo[b, f Jtiepin. Into a mixture of 12 g of 10,11-dihydro-2-(dimethyl-sulfamoyl)-dibenzo[b,f]thiepin-10-ol, 250 ml of benzene and 20 g of calcium chloride are introduced at 10° in the course of 2 hours of hydrochloric acid gas. The reaction mixture was then allowed to stand for 20 hours at room temperature. When nitrogen is introduced, the excess hydrochloric acid is expelled. It is all filtered off and evaporated under reduced pressure. One obtains 10-chloro-10,11-dihydro-2-(dimethylsulfamoyl)-dibenzo[b,f Jtiepine.
EKSEMPEL 12 EXAMPLE 12
På samme måte som angitt i eksempel 3 får man: •1-[2-[4-(2-klor-10,11-dihydro-dibenzo[b,f]tiepin-10-yl)-1-piperazinyl]-etyl]-2-pyrrolidinonet fra 1-(2-klor-10,11-dihydro-dibenzo [b, f ]tiepin-lO-yl) -piperazin og 1-(2-kloretyl)-2- pyrrolidinon. Det tilsvarende maleat tilberedes i aceton og omkrystalliseres fra vann; Smp. 179-180°. 3- [3-[4-(10,ll-dihydro-2-metyl-dibenzo[b,f]tiepin-10-yl)-1-piperazinyl]-propyl]-2-oksazolidinonet fra 1-(10,ll-dihydro-2-metyl-dibenzo[b,fjtiepin-10-yl)-piperazin og 3-(3-klorpropyl)-2-oksazolidinon. Smp. 144-145°. Det i aceton tilberedte dimaleat smelter ved 140-142°. 1- [2-[4-(2-klor-10,11-dihydro-dibenzo [b,fjtiepin-10-yl)-1-piperazinyl]etyl]-2-benzimidazolinonet fra 1-(2-klor-10,11-dihydro-dibenzo [b, f jtiepin- 10-yl) -piperazin og 1-(2-kloretyl)-2- benzimidazolinon. Smp. 161-164°. Det i metanol og eter tilberedte bis-(metansulfonat) smelter ved 160-165° (spaltning). l-[2-[4-(2-klor-10,11-dihydro-dibenzo[b,fjtiepin-10-yl)-1-piperazinylj-etylJ-2-piperidonet fra 1-(2-klor-10,11-dihydro-dibenzo[b,fjtiepin-10-yl)-piperazin og 1-(2-kloretyl)-2-piperidon. Smp. 133°. Det i etanol tilberedte bis-(metansulfo~ nat) smelter ved 156-159° (spaltning). In the same way as stated in example 3, you get: •1-[2-[4-(2-chloro-10,11-dihydro-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-ethyl ]-2-pyrrolidinone from 1-(2-chloro-10,11-dihydro-dibenzo[b,f]thiepin-10-yl)-piperazine and 1-(2-chloroethyl)-2-pyrrolidinone. The corresponding maleate is prepared in acetone and recrystallized from water; Temp. 179-180°. 3-[3-[4-(10,11-dihydro-2-methyl-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-propyl]-2-oxazolidinone from 1-(10,11 -dihydro-2-methyl-dibenzo[b,fthiepin-10-yl)-piperazine and 3-(3-chloropropyl)-2-oxazolidinone. Temp. 144-145°. The dimaleate prepared in acetone melts at 140-142°. 1- [2-[4-(2-chloro-10,11-dihydro-dibenzo [b,fthiepin-10-yl)-1-piperazinyl]ethyl]-2-benzimidazolinone from 1-(2-chloro-10, 11-dihydro-dibenzo[b,f jthiepin-10-yl)-piperazine and 1-(2-chloroethyl)-2-benzimidazolinone. Temp. 161-164°. The bis-(methanesulfonate) prepared in methanol and ether melts at 160-165° (decomposition). 1-[2-[4-(2-chloro-10,11-dihydro-dibenzo[b,fthiepin-10-yl)-1-piperazinyl-ethyl]-2-piperidone from 1-(2-chloro-10,11 -dihydro-dibenzo[b,fthiepin-10-yl)-piperazine and 1-(2-chloroethyl)-2-piperidone. Temp. 133°. The bis-(methanesulfonate) prepared in ethanol melts at 156-159° (decomposition).
1_[2-[4-(10,ll-dihydro-2-metyl-dibenzo[b,f jtiepin-10-yl)-1-piperazinylj-etyl}-2-pyrrolidinonet fra 1-(IO,ll-dihydro-2-metyl-dibenzo[b,fjtiepin-10-yl)-piperazin og 1-(2-kloretyl-2-pyrrolidinon. Det tilsvarende maleat smelter ved 142-144°. 1_[2-[4-(10,11-dihydro-2-methyl-dibenzo[b,f jthiepin-10-yl)-1-piperazinyl-ethyl}-2-pyrrolidinone from 1-(10,11-dihydro- 2-methyl-dibenzo[b,fthiepin-10-yl)-piperazine and 1-(2-chloroethyl-2-pyrrolidinone. The corresponding maleate melts at 142-144°).
EKSEMPEL 13 EXAMPLE 13
17 g 10-klor-lO,ll-dihydro-2-trifluormetyl-dibenzo[b,fjtiepin i 90 ml kloroform og 26,2 g 3-[2-(1-piperazinyl)-etylJ-2-oksazolidinon oppvarmes 14 timer under tilbakelopsbetingelser. Reaksjonsblandingen dampes inn og resten tilsettes isvann, eter og 2N vandig natriumhydroksyd. Etter ekvilibreringen vaskes den organiske fase med vann og ansyres med etanolisk saltsyre. Den utfallende felling filtreres av og loses opp i ca. 400 ml vann? den vandige opplosning ekstraheres med eter. Den vandige opplosning tilsettes is, stilles alkalisk med vandig natriumhydroksydopplosning og ekstraheres med ca. 350 ml benzen. Benzenfasen torkes over natriumsulfat, filtreres og dampes inn. Man får 3-[2-[4-(10,ll-dihydro-2-trifluormetyl-dibenzo[b,f]tiepin-10-yl)-1-piperazinyl]-etyl]-2-oksazolidinon som en olje. 'Ved omsetning med maleinsyre får man det tilsvarende maleat, som krystalliserer fra etanol-eter; 17 g of 10-chloro-10,11-dihydro-2-trifluoromethyl-dibenzo[b,fthiepine in 90 ml of chloroform and 26.2 g of 3-[2-(1-piperazinyl)-ethyl]-2-oxazolidinone are heated for 14 hours under backflow conditions. The reaction mixture is evaporated and the residue is added to ice water, ether and 2N aqueous sodium hydroxide. After equilibration, the organic phase is washed with water and acidified with ethanolic hydrochloric acid. The resulting precipitate is filtered off and dissolved in approx. 400 ml of water? the aqueous solution is extracted with ether. The aqueous solution is added to ice, made alkaline with aqueous sodium hydroxide solution and extracted with approx. 350 ml of benzene. The benzene phase is dried over sodium sulphate, filtered and evaporated. 3-[2-[4-(10,11-dihydro-2-trifluoromethyl-dibenzo[b,f]thiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone is obtained as an oil. 'By reaction with maleic acid, the corresponding maleate is obtained, which crystallizes from ethanol-ether;
smp. 168-169°. m.p. 168-169°.
Det som utgangsmateriale anvendte 10-klor-10, ll-dihydro-2-trifluormetyl-dibenzo[b,f]tiepin kan|fremstilles som folger: i ■ The 10-chloro-10,11-dihydro-2-trifluoromethyl-dibenzo[b,f]thiepine used as starting material can be prepared as follows: i ■
En opplosning av 6,5 g kaliumhydroksy/d :i 86 ml vann tilsettes A solution of 6.5 g of potassium hydroxy/d in 86 ml of water is added
i en nitrogenatmosfære ved 50° 10,3-,-inl tiofenol og étterrores i 30 minutter. Etter tilsetning av 6;5 g kobberpulver og 22,5 g 4-klor—3—nitro-benzotrifluorid i 100 ml etanol oppvarmes det hele 48 timer under tilbakelopsbetingelser. Etter filtrering in a nitrogen atmosphere at 50° 10,3-,-inl thiophenol and refluxed for 30 minutes. After adding 6.5 g of copper powder and 22.5 g of 4-chloro-3-nitro-benzotrifluoride in 100 ml of ethanol, the mixture is heated for 48 hours under reflux conditions. After filtering
irir
helles reaksjonsblandingen på vann og ekstraheres med eter. Det eteriske fase vaskes etter hverandre med vandig natriumkarbonatopplosning, vann, vandig kokfaltopplosning, 2N vandig saltsyre og vann,, torkes, f iltrere sfogjxiampes inn. Man får 3—nitro-4-(fenyltio)-benzotrifluoriÉæm en rod olje. the reaction mixture is poured onto water and extracted with ether. The ethereal phase is washed successively with aqueous sodium carbonate solution, water, aqueous cokefal solution, 2N aqueous hydrochloric acid and water, dried, f filters are filtered. 3-nitro-4-(phenylthio)-benzotrifluoride is obtained as a red oil.
26,9 g 3-nitro-4-(fenyltio)-benzotrifluorid i 250 ml etanol hydrogeneres i nærvær av 10 g Raney-nikkel ved romtemperatur og atmosfærisk trykk 17 timer. Reaksjonsblandingen filtreres og dampes inn under redusert trykk. Man får 3-amino-4-(fenyltio)-benzotrifluorid som en rodbrun olje. Forbindelsen destilleres under sterkt redusert trykk og koker ved 110-135° (0,1 mm; orange-farget olje). 26.9 g of 3-nitro-4-(phenylthio)-benzotrifluoride in 250 ml of ethanol are hydrogenated in the presence of 10 g of Raney nickel at room temperature and atmospheric pressure for 17 hours. The reaction mixture is filtered and evaporated under reduced pressure. 3-amino-4-(phenylthio)-benzotrifluoride is obtained as a red-brown oil. The compound is distilled under greatly reduced pressure and boils at 110-135° (0.1 mm; orange-coloured oil).
36 g 3-amino-4-(fenyltio)-benzotrifluorid, 70 ml vann og 36 g of 3-amino-4-(phenylthio)-benzotrifluoride, 70 ml of water and
21 ml metansulfonsyre oppvarmes til 90°, rores om i 20 minutter ved denne temperatur og kjoles deretter av til 0°. 21 ml of methanesulfonic acid is heated to 90°, stirred for 20 minutes at this temperature and then cooled to 0°.
Den oppnådde suspensjon tilsettes dråpevis ved 0° i lopet av The obtained suspension is added dropwise at 0° in the course of
15 minutter en opplosning på 9,25 g natriumnitrit i 33 ml vann, hvorved det passes på at temperaturen ikke overstiger 10°. Reaksjonsblandingen rores om i ca. 1 time ved 0°, filtreres og 'tilsettes i lopet av ca. 45 minutter til en til 100° for- 15 minutes a solution of 9.25 g of sodium nitrite in 33 ml of water, whereby care is taken that the temperature does not exceed 10°. The reaction mixture is stirred for approx. 1 hour at 0°, filtered and added over the course of approx. 45 minutes to a to 100° for-
varmet kobbercyanidsuspensjon (fremstilt ved tilsetning av 33,75 g kobbersulfat til 37 g kaliumcyanid i 165 ml vann). heated copper cyanide suspension (prepared by adding 33.75 g of copper sulfate to 37 g of potassium cyanide in 165 ml of water).
Den oppnådde morke reaksjonsoppldsning rores om i 1 time ved The obtained dark reaction solution is stirred for 1 hour
100°, kjoles av, tilsettes 350 ml benzen og rores om over natten. Blandingen filtreres gjennom diatomé-jord og filter-kaken ettervaskes med benzen. Den organiske fase vaskes to ganger hver gang med 150 ml mettet natriumkloridopplosning, 100°, cool off, add 350 ml of benzene and stir overnight. The mixture is filtered through diatomaceous earth and the filter cake is washed with benzene. The organic phase is washed twice each time with 150 ml of saturated sodium chloride solution,
torkes over natriumsulfat, filtreres og dampes inn. Man oppnår 2-(fenyltio)-5-trifluormetyl-benzonitril som en mork olje. 6 g 2-(fenyltio)-5-trifluormetyl-benzonitril, 40 ml 15%'ig vandig natriumhydroksydopplosning og 12 ml etanol oppvarmes 12 timer under tilbakelopsbetingelser og kjoles av. Etter tilsetning av 100 ml vann ekstraheres det hele med 80 ml benzen. Den vandige fase kjoles av til 0° og ansyres med konsentrert saltsyre. Den utfallende felling ekstraheres med metylen- dried over sodium sulphate, filtered and evaporated. 2-(phenylthio)-5-trifluoromethyl-benzonitrile is obtained as a dark oil. 6 g of 2-(phenylthio)-5-trifluoromethyl-benzonitrile, 40 ml of 15% aqueous sodium hydroxide solution and 12 ml of ethanol are heated for 12 hours under reflux conditions and cooled. After adding 100 ml of water, the whole is extracted with 80 ml of benzene. The aqueous phase is cooled to 0° and acidified with concentrated hydrochloric acid. The resulting precipitate is extracted with methylene
klorid. Den organiske fase vaskes med vann inntil noytral reaksjon, torkes over natriumsulfat, filtreres og dampes inn. Man får 2-(fenyltio)-5-trifluormetyl-benzoesyre, som smelter ved 140-145°. chloride. The organic phase is washed with water until the reaction is neutral, dried over sodium sulphate, filtered and evaporated. 2-(phenylthio)-5-trifluoromethyl-benzoic acid is obtained, which melts at 140-145°.
100 g 2-(fenyltio)-5-trifluormetyl-benzoesyre, 750 ml absolutt metanol og 100 ml svovelsyre oppvarmes 72 timer under tilbakelopsbetingelser. Reaksjonsopplosningen konsentreres under redusert trykk og tilsettes vann og benzen. Etter ekvilibreringen vaskes den organiske fase etter hverandre med mettet vandig koksaltopplosning, mettet vandig natriumbikarbonatopplosning og mettet vandig koksaltopplosning. Benzenfasen torkes deretter over natriumsulfat, filtreres og dampes inn. 100 g of 2-(phenylthio)-5-trifluoromethyl-benzoic acid, 750 ml of absolute methanol and 100 ml of sulfuric acid are heated for 72 hours under reflux conditions. The reaction solution is concentrated under reduced pressure and water and benzene are added. After equilibration, the organic phase is washed successively with saturated aqueous sodium bicarbonate solution, saturated aqueous sodium bicarbonate solution and saturated aqueous sodium bicarbonate solution. The benzene phase is then dried over sodium sulphate, filtered and evaporated.
Man får 2-(fenyltio)-5-trifluormetyl-benzoesyre-metylester som 2-(Phenylthio)-5-trifluoromethyl-benzoic acid methyl ester is obtained as
en gul olje. a yellow oil.
21,5 g litiumborhydrid suspenderes i en nitrogenatmosfære i 375 ml tetrahydrofuran og oppvarmes til tilbakelopstemperatur. Under tilbakelopsbetingelser tilsettes denne suspensjon dråpevis med en opplosning av 130 g 2-(fenyltio)-5-trifluormetyl-benzosyre-metylester i 600 ml tetrahydrofuran i lopet av 20 minutter. Reaksjonsblandingen rores om i 2 timer under tilbakelopsbetingelser og kjoles deretter av til 2°. i lopet av 21.5 g of lithium borohydride are suspended in a nitrogen atmosphere in 375 ml of tetrahydrofuran and heated to reflux temperature. Under reflux conditions, this suspension is added dropwise with a solution of 130 g of 2-(phenylthio)-5-trifluoromethyl-benzoic acid methyl ester in 600 ml of tetrahydrofuran over the course of 20 minutes. The reaction mixture is stirred for 2 hours under reflux conditions and then cooled to 2°. during
10 minutter tilsettes 450 ml 2N vandig saltsyre på en slik måte at temperaturen ikke overstiger 10°. Etter tilsetning av 750 ml vann ekstraheres det hele med 1000 ml eter. Den organiske fase vaskes to ganger, hver gang med 300 ml vann, torkes over natriumsulfat, filtreres og dampes inn. Man får 2-(fenyltio)-5-trifluormetyl-benzyl-alkohol som en lysgul olje, som krystalliserer spontant; smp. 84°. 96 g 2-(fenyltio)-5-trifluormetyl-benzylalkohol opploses i 450 ml absolutt benzen og oppvarmes til tilbakelopstemperatur. Den slik oppnådde opplosning tilsettes dråpevis i lopet av 20 minutter med 48 ml tionylklorid og rores deretter om 30 min. ved tilbakelopstemperatur. Etter avkjoling dampes reaksjonsblandingen inn under redusert trykk. Man får 2-(fenyltio-5-trifluormetyl-benzylklorid som en brungul olje. After 10 minutes, 450 ml of 2N aqueous hydrochloric acid is added in such a way that the temperature does not exceed 10°. After adding 750 ml of water, the whole is extracted with 1000 ml of ether. The organic phase is washed twice, each time with 300 ml of water, dried over sodium sulphate, filtered and evaporated. 2-(phenylthio)-5-trifluoromethyl-benzyl alcohol is obtained as a pale yellow oil, which crystallizes spontaneously; m.p. 84°. 96 g of 2-(phenylthio)-5-trifluoromethyl-benzyl alcohol are dissolved in 450 ml of absolute benzene and heated to reflux temperature. The solution thus obtained is added dropwise over 20 minutes with 48 ml of thionyl chloride and is then stirred for 30 minutes. at reflux temperature. After cooling, the reaction mixture is evaporated under reduced pressure. 2-(phenylthio-5-trifluoromethyl-benzyl chloride) is obtained as a brownish-yellow oil.
11,2 g natriumcyanid i 135 ml dimetylsulfoksyd oppvarmes til 40° og tilsettes i lopet av 10 minutter en opplosning av 87 g 2-(fenyltio)-5-trifluormetyl-benzylklorid i 72 ml dimetylsulfoksyd dråpevis. Det hele rores om i 9 timer ved 40°, avkjoles til romtemperatur, tilsettes 200 ml vann og ekstraheres med 200 ml eter. Den vandige fase ekstraheres to ganger, hver gang med 100 ml eter. De forenede organiske faser vaskes nå to ganger, hver gang med 200 ml vann, torkes over natriumsulfat og dampes inn under redusert trykk. Man får 2-(fenyltio)-5-trifluormetyl-fenylacetonitril som en morkrod olje. 11.2 g of sodium cyanide in 135 ml of dimethyl sulphoxide are heated to 40° and a solution of 87 g of 2-(phenylthio)-5-trifluoromethyl-benzyl chloride in 72 ml of dimethyl sulphoxide is added dropwise over the course of 10 minutes. The whole is stirred for 9 hours at 40°, cooled to room temperature, 200 ml of water are added and extracted with 200 ml of ether. The aqueous phase is extracted twice, each time with 100 ml of ether. The combined organic phases are now washed twice, each time with 200 ml of water, dried over sodium sulphate and evaporated under reduced pressure. 2-(phenylthio)-5-trifluoromethyl-phenylacetonitrile is obtained as a horseradish oil.
15 g 2-(fenyltio)-5-trifluormetyl-fenylacetonitril, 15,1 g natriumhydroksyd, 90 ml vann og 23 ml etanol oppvarmes 12 timer under tilbakelopsbetingelser og konsentreres deretter. Resten ekstraheres, etter tilsetning av 200 ml vann, med 100 ml 15 g of 2-(phenylthio)-5-trifluoromethyl-phenylacetonitrile, 15.1 g of sodium hydroxide, 90 ml of water and 23 ml of ethanol are heated for 12 hours under reflux conditions and then concentrated. The residue is extracted, after adding 200 ml of water, with 100 ml
benzen. Den vandige fase etter-ekstraheres med 50 ml benzen. benzene. The aqueous phase is then extracted with 50 ml of benzene.
De forenede organiske faser ekstraheres med 0,5N vandig natriumhydroksydopplosning. Den vandige fase ansyres med saltsyre og ekstraheres med 150 ml kloroform. Den organiske fase vaskes med vandig koksaltopplosning, torkes og dampes inn. The combined organic phases are extracted with 0.5N aqueous sodium hydroxide solution. The aqueous phase is acidified with hydrochloric acid and extracted with 150 ml of chloroform. The organic phase is washed with aqueous sodium chloride solution, dried and evaporated.
Man får 2-(fenyltio)-5-trifluormetyl-fenyleddiksyre som krystaller som smelter ved 102-103°. 2-(phenylthio)-5-trifluoromethyl-phenylacetic acid is obtained as crystals melting at 102-103°.
217 g polyfosforsyre oppvarmes i en nitrogenatmosfære til 110°, tilsettes 21 g 2-(fenyltio)-5-trifluormetyl-fenyleddik-syre og rores i 8 minutter ved 100-110°. Det hele avkjoles og tilsettes 100 g is og 250 ml isvann. Det hele ekstraheres med 30O ml benzen. Den organiske fase vaskes etter hverandre to ganger, hver gang med 150 ml vann, to ganger, hver gang med 200 ml mettet vandig natriumkarbonatopplosning og en gang med 150 ml vandig natriumkloridopplosning, torkes over natriumsulfat, filtreres og dampes inn under redusert trykk. Man får 10,11-dihydro-2-trifluormetyl-dibenzo[b,fJtiepin-lO-on som lysgule krystaller som smelter ved 103-104°. 12 g 10,ll-dihydro-2-trifluormety1-dibenzo[b,f]tiepin-10-on opploses i 110 ml absolutt etanol og tilsettes 4 g natriumborhydrid. Det hele holdes 12 minutter ved tilbakelopstemperatur, avkjoles til 3o° og tilsettes 350 ml vann og lOO ml kloroform» Etter ekvilibreringen vaskes den organiske fase med vandig koksaltopplosning, torkes over natriumsulfat og dampes inn under redusert trykk. Man får 10,ll-dihydro-2-trifluormetyl-dibenzo[b,fJtiepin-lO-ol som gule krystaller som smelter ved 122-123°. 217 g of polyphosphoric acid are heated in a nitrogen atmosphere to 110°, 21 g of 2-(phenylthio)-5-trifluoromethyl-phenylacetic acid are added and stirred for 8 minutes at 100-110°. The whole thing is cooled and 100 g of ice and 250 ml of ice water are added. The whole is extracted with 300 ml of benzene. The organic phase is successively washed twice, each time with 150 ml of water, twice, each time with 200 ml of saturated aqueous sodium carbonate solution and once with 150 ml of aqueous sodium chloride solution, dried over sodium sulfate, filtered and evaporated under reduced pressure. 10,11-dihydro-2-trifluoromethyl-dibenzo[b,fJtiepin-10-one is obtained as pale yellow crystals melting at 103-104°. 12 g of 10,11-dihydro-2-trifluoromethyl-dibenzo[b,f]thiepin-10-one are dissolved in 110 ml of absolute ethanol and 4 g of sodium borohydride are added. The whole is kept for 12 minutes at reflux temperature, cooled to 3o° and 350 ml of water and 100 ml of chloroform are added. After equilibration, the organic phase is washed with aqueous sodium chloride solution, dried over sodium sulphate and evaporated under reduced pressure. 10,11-dihydro-2-trifluoromethyl-dibenzo[b,fJtiepin-10-ol is obtained as yellow crystals melting at 122-123°.
11,4 g 10,ll-dihydro-2-trifluormetyl-dibenzo[b,fJtiepin-lO-ol, lOO ml benzen og 4 g kalsiumklorid mettes ved 15° i lopet av 2 timer med saltsyregass og rores deretter om i 3 timer ved romtemperatur. Reaksjonsblandingen filtreres og konsentreres under redusert trykk. Man får 10-klor-10,ll-dihydro-2-trifluor-metyl-dibenzo[b,fJtiepin som gule krystaller. 11.4 g of 10,11-dihydro-2-trifluoromethyl-dibenzo[b,fJthiepin-10-ol, 100 ml of benzene and 4 g of calcium chloride are saturated at 15° over the course of 2 hours with hydrochloric acid gas and then stirred for 3 hours at room temperature. The reaction mixture is filtered and concentrated under reduced pressure. 10-chloro-10,11-dihydro-2-trifluoromethyl-dibenzo[b,f]thiepine is obtained as yellow crystals.
EKSEMPEL 14 (mellomprodukt) EXAMPLE 14 (intermediate)
8, 5 g 2-klor-10,11-dihydro-dibenzo[b,f]tiepin-10-on, 30 g 3-[2-(1-piperazinyl)-etyl]-2-oksazolidinon og 100 ml benzen tilsettes dråpevis i en argonatmosfære ved 20° 5,2 g titan-tetraklorid i 25 ml benzen. Reaksjonsblandingen oppvarmes 20 timer under tilbakelopsbetingelser og helles deretter på 8.5 g of 2-chloro-10,11-dihydro-dibenzo[b,f]thiepin-10-one, 30 g of 3-[2-(1-piperazinyl)-ethyl]-2-oxazolidinone and 100 ml of benzene are added dropwise in an argon atmosphere at 20° 5.2 g of titanium tetrachloride in 25 ml of benzene. The reaction mixture is heated for 20 hours under reflux conditions and then poured on
en blanding av is og vandig natriumbikarbonatopplosning. Det hele rores om 1 time og filtreres gjennom diatomé-jord. Den vandige fase skilles fra og vaskes etter hverandre med benzen og kloroform. De organiske faser konsentreres og vaskes etter hverandre med vandig koksaltopplosning og vann, torkes, filtreres og dampes inn under redusert trykk. Man får 3-E.-2-[4-(2-klor-dibenzo[b,f Jtiepin-10-yl)-l-piperazinyl]-etyl]-2-oksazolidinon som en rodbrun, viskos olje, som for rensning kromatograferes på 100 g siliciumdioksyd (lopemiddel etanol: metanol:konsentrert ammoniakk 100:50:10). Man får en rodbrun olje som krystalliseres fra aceton under anvendelse av aktivt kull. Man får beige-fargede krystaller som ved omsetning med maleinsyre i aceton overfores til det tilsvarende maleat (beige-fargede krystaller) med smeltepunkt 232-233° (spaltning). a mixture of ice and aqueous sodium bicarbonate solution. The whole thing is stirred for 1 hour and filtered through diatomaceous earth. The aqueous phase is separated and washed successively with benzene and chloroform. The organic phases are concentrated and washed successively with aqueous sodium chloride solution and water, dried, filtered and evaporated under reduced pressure. 3-E.-2-[4-(2-chloro-dibenzo[b,f Jthiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone is obtained as a red-brown, viscous oil, which for purification chromatographed on 100 g of silicon dioxide (eluent ethanol: methanol: concentrated ammonia 100:50:10). A red-brown oil is obtained which is crystallized from acetone using activated charcoal. Beige-coloured crystals are obtained which, on reaction with maleic acid in acetone, are converted to the corresponding maleate (beige-coloured crystals) with a melting point of 232-233° (decomposition).
EKSEMPEL 15 EXAMPLE 15
I en argonatmosfære tilsettes dråpevis 750 mg 3-[2-[4-(2-klor-dibenzo[b,f Jtiepin-10-yl)-l-piperazinyl]etyl]-2-oksazolidinon, 0,6 g natriumborhydrid og 30 ml diglymer ved 20-30° i lopet av 15 minutter med 2,7 g oksalsyre-dihydrat i 15 ml diglymer. Reaksjonsblandingen oppvarmes 4 timer ved en indre temperatur på 100° og dampes deretter inn under redusert trykk. Resten tilsettes kloroform og 2N natriumhydroksydopplosning. Etter ekvilibreringen skilles den vandige fase fra og vaskes to ganger med kloroform. De forenede kloroformekstrakter vaskes med vann, torkes over kaliumkarbonat og aktivt kull, filtreres og dampes inn under redusert trykk. Man får 3-[-2-[4-(2-klor-10,ll-dihydrb-dibenzo[b,f Jtiepin-10-yl)-1-piperazinylJ-etyl]-2-oksazolidinon som en brun olje. Maleatet fremstilles ved omsetning med maleinsyre i etanol-eter; smp. 173-175°. In an argon atmosphere, 750 mg of 3-[2-[4-(2-chloro-dibenzo[b,f Jthiepin-10-yl)-1-piperazinyl]ethyl]-2-oxazolidinone, 0.6 g of sodium borohydride and 30 ml of diglymer at 20-30° over the course of 15 minutes with 2.7 g of oxalic acid dihydrate in 15 ml of diglymer. The reaction mixture is heated for 4 hours at an internal temperature of 100° and then evaporated under reduced pressure. Chloroform and 2N sodium hydroxide solution are added to the residue. After equilibration, the aqueous phase is separated and washed twice with chloroform. The combined chloroform extracts are washed with water, dried over potassium carbonate and activated charcoal, filtered and evaporated under reduced pressure. 3-[-2-[4-(2-chloro-10,11-dihydrob-dibenzo[b,f Jthiepin-10-yl)-1-piperazinyl]-ethyl]-2-oxazolidinone is obtained as a brown oil. The maleate is produced by reaction with maleic acid in ethanol-ether; m.p. 173-175°.
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1100172A CH569013A5 (en) | 1972-07-21 | 1972-07-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO138695B true NO138695B (en) | 1978-07-17 |
NO138695C NO138695C (en) | 1978-10-25 |
Family
ID=4369013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO296373A NO138695C (en) | 1972-07-21 | 1973-07-20 | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TRICYCLIC COMPOUNDS |
Country Status (8)
Country | Link |
---|---|
DD (1) | DD111908A5 (en) |
FI (1) | FI57413C (en) |
HU (1) | HU168042B (en) |
IE (1) | IE37914B1 (en) |
IL (1) | IL42585A0 (en) |
NO (1) | NO138695C (en) |
SU (1) | SU490287A3 (en) |
ZA (1) | ZA734176B (en) |
-
1973
- 1973-06-20 ZA ZA734176A patent/ZA734176B/en unknown
- 1973-06-22 IL IL42585A patent/IL42585A0/en unknown
- 1973-07-16 IE IE119373A patent/IE37914B1/en unknown
- 1973-07-16 FI FI224873A patent/FI57413C/en active
- 1973-07-19 HU HUHO001596 patent/HU168042B/hu unknown
- 1973-07-19 DD DD17236773A patent/DD111908A5/xx unknown
- 1973-07-20 NO NO296373A patent/NO138695C/en unknown
- 1973-07-20 SU SU1943851A patent/SU490287A3/en active
Also Published As
Publication number | Publication date |
---|---|
HU168042B (en) | 1976-02-28 |
IE37914L (en) | 1974-01-21 |
FI57413C (en) | 1980-08-11 |
SU490287A3 (en) | 1975-10-30 |
DD111908A5 (en) | 1975-03-12 |
IE37914B1 (en) | 1977-11-09 |
FI57413B (en) | 1980-04-30 |
IL42585A0 (en) | 1973-08-29 |
NO138695C (en) | 1978-10-25 |
ZA734176B (en) | 1974-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4430343A (en) | Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same | |
NO162965B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALFA- (2-OXO-2,4,5,6,7,7A-HEXSAHYDROTIENO- (3,2-C) -5-PYRIDYL) -PHENYL-ACETIC ACID DERIVATIVES. | |
NO122814B (en) | ||
DK158346B (en) | METHOD OF ANALOGY FOR THE PREPARATION OF 4-AMINO-5-ALKYL SULPHONYL-O-ANISAMIDE DERIVATIVES AND 2-METHOXY-4-AMINO-5-ALKYLSULPHONYL BENZOIC ACIDS FOR USE AS INTERMEDIATRIC FRUIT SODANE FRUIT ACRODUCED FRUIT SODANE FRACTIONS THROUGH ANIMAL SUCCESS | |
NO164349B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE N- (PIPERIDINYL-ALKYL) CARBOXAMIDES AND THEIR SALTS. | |
NO165240B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BENZOTIAZINE Dioxide DERIVATIVES. | |
DE2336130A1 (en) | TRICYCLIC LINKS | |
NO813066L (en) | ISOQINOLINE DERIVATIVES, PROCEDURES FOR THEIR PREPARATION, PHARMACEUTICAL PREPARATIONS, CONTENTS AND THEIR USE | |
RU2188197C2 (en) | 1,4-disubstituted piperazines, method of their synthesis, pharmaceutical composition and method of treatment of neurogenic inflammation | |
DK168010B1 (en) | TETRAHYDROISOQUINOL COMPOUNDS AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH A COMPOUND | |
Metlesics et al. | Condensation of o-benzoylbenzaldehyde with aliphatic diamines | |
NO158739B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-PIPERAZINOPYRIMIDINE DERIVATIVES. | |
CA1254561A (en) | 3-aminocarbonylmethoxy-5-phenylpyrazole compounds, method of their preparation and pharmaceutical compositions containing these compounds | |
NO159090B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDOINDOL DERIVATIVES. | |
CZ325196A3 (en) | Derivatives of hydroximic acid, pharmaceutical compositions containing thereof, process of their preparation and intermediates used in the preparation process | |
NO138695B (en) | ANALOGICAL PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE TRICYCLIC COMPOUNDS | |
US4237135A (en) | 2-(4-Ethyl-1-piperazinyl)-4-phenylquinoline, process for preparation thereof, and composition thereof | |
US3954764A (en) | Dibenzo [b,f]thiepins bearing piperazinyl substitution | |
Huckle et al. | 4-Amino-2, 3, 4, 5-tetrahydro-1-benzoxepin-5-ols, 4-amino-2, 3, 4, 5-tetrahydro-1-benzothiepin-5-ols, and related compounds | |
DE2412520A1 (en) | TRICYCLIC LINKS | |
DK149889B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF DIBENZO (D, G) (1,3,6) DIOXAZOCINE DERIVATIVES OR ACID ADDITION SALTS THEREOF | |
DK143752B (en) | METHOD OF ANALOGUE FOR PREPARING PYRIDOBENZODIAZEPINON OR PHARMACOLOGICAL ACCEPTABLE SALTS THEREOF | |
NO754001L (en) | ||
DK150158B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF 4-PHENYLTHIENO- (2,3-C) PIPERIDINES OR PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS THEREOF | |
US4044010A (en) | Dibenzo[b,f] thiepins bearing piperazinyl substitution |